var title_f28_17_28944="Barretts methylene blue";
var content_f28_17_28944=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60183&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60183&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chromoendoscopy of Barrett's esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 443px; height: 221px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic views of short-segment Barrett's esophagus (left panel) and long-segment Barrett's esophagus (right panel) seen after staining with methylene blue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marcia I Canto, MD, MHS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28944=[""].join("\n");
var outline_f28_17_28944=null;
var title_f28_17_28945="TAPP hernia reduction";
var content_f28_17_28945=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F71264&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F71264&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 494px\">",
"   <div class=\"ttl\">",
"    TAPP hernia reduction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 474px; height: 411px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Jones, DB, Maithel, SK, Schneider, BE. Atlas of minimally invasive surgery. Cin&eacute;-Med, Woodbury, CT 2006. Copyright &copy; 2006 Cin&eacute;-Med, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28945=[""].join("\n");
var outline_f28_17_28945=null;
var title_f28_17_28946="Interscalene brachial plexus block";
var content_f28_17_28946=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F51630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F51630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 526px\">",
"   <div class=\"ttl\">",
"    Interscalene brachial plexus block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 506px; height: 506px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The sternal notch, sternal and clavicular heads of sternocleidomastoid muscle, and clavicle are identified and marked. The groove between the anterior and middle scalene muscles is palpated, the needle inserted (red dot) perpendicular to the skin plane with a slightly caudad orientation, and local anesthetic infused when appropriate nerve stimulation elicited.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28946=[""].join("\n");
var outline_f28_17_28946=null;
var title_f28_17_28947="Heparin necrosis purpura";
var content_f28_17_28947=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F71259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F71259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Heparin necrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Purpuric lesions and skin necrosis are present in this patient with heparin necrosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28947=[""].join("\n");
var outline_f28_17_28947=null;
var title_f28_17_28948="Assessment of perfusion in pediatric resuscitation";
var content_f28_17_28948=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Assessment of perfusion in pediatric resuscitation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28948/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28948/contributors\">",
"     Pamela Bailey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28948/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28948/contributors\">",
"     Susan B Torrey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28948/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28948/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/17/28948/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of cardiopulmonary resuscitation is the repair of deficits in ventilation, oxygenation, and perfusion. Rapid assessment of the adequacy of systemic perfusion is an essential part of pediatric resuscitation. It is accomplished by evaluation of mental status, capillary refill, pulses, and blood pressure.",
"   </p>",
"   <p>",
"    The pathophysiology of the maintenance of cardiac output and assessment of perfusion during pediatric resuscitation are reviewed here. Epidemiology and outcome of pediatric resuscitation, cardiopulmonary resuscitation, and medications used in resuscitation are discussed separately. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MAINTENANCE OF CARDIAC OUTPUT AND PERFUSION PRESSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial blood pressure is the product of cardiac output and systemic vascular resistance (",
"    <a class=\"graphic graphic_figure graphicRef74895 \" href=\"UTD.htm?7/56/8077\">",
"     figure 1",
"    </a>",
"    ). Cardiac output is the volume of blood ejected by the heart each minute; it is the product of heart rate and stroke volume. The stroke volume is the volume of blood ejected by the ventricles with each contraction; it may be reduced by inadequate intravascular volume, myocardial dysfunction, or excessive systemic or pulmonary vascular resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/1\">",
"     1",
"    </a>",
"    ]. Cardiac output declines if either heart rate or stroke volume decrease without a commensurate increase in the other component.",
"   </p>",
"   <p>",
"    During childhood, the heart rate is faster and the stroke volume is smaller than during adulthood. In children, particularly in infants, cardiac output is increased primarily by increasing the heart rate [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Animal studies suggest that infants are able to increase stroke volume, but changes in heart rate have a greater effect on cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Heart rate and blood pressure are the only variables affecting cardiac output that can be directly and noninvasively measured. Stroke volume may be indirectly assessed by examining the volume and strength of the pulses. Systemic vascular resistance may be estimated by evaluating skin perfusion. Examination of the jugular veins to estimate venous pressure also may be useful in assessing the volume status in older children and adolescents. However, because low values may be normal, this technique is most useful in distinguishing among the causes of generalized edema. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/36/34375?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical manifestations and diagnosis of edema in adults\", section on 'Distribution of edema and central venous pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tachycardia and prolonged capillary refill are clinical manifestations of compensatory mechanisms designed to maintain a normal arterial perfusion pressure in the face of cardiopulmonary compromise. However, these compensatory mechanisms can be maintained only until cardiac reserve is depleted. Systemic vasoconstriction increases left ventricular afterload and myocardial oxygen consumption. Tachycardia, which also increases myocardial oxygen consumption, can be marked in an ill child. Hypotension is a late and often sudden sign of cardiovascular decompensation (",
"    <a class=\"graphic graphic_figure graphicRef74944 \" href=\"UTD.htm?36/5/36957\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MENTAL STATUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Change in the level of consciousness of a child may indicate decreased cerebral oxygenation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    perfusion or may be caused by direct cerebral injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/4\">",
"     4",
"    </a>",
"    ]. Decreasing levels of consciousness can be described by the AVPU classification [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/2\">",
"     2",
"    </a>",
"    ]. In this system, the child may be described as:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <strong>",
"       A: A",
"      </strong>",
"      wake",
"     </li>",
"     <li>",
"      <strong>",
"       V:",
"      </strong>",
"      Responsive to",
"      <strong>",
"       V",
"      </strong>",
"      oice",
"     </li>",
"     <li>",
"      <strong>",
"       P:",
"      </strong>",
"      Responsive only to",
"      <strong>",
"       P",
"      </strong>",
"      ain",
"     </li>",
"     <li>",
"      <strong>",
"       U: U",
"      </strong>",
"      nresponsive",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    More profound degrees of hypoperfusion produce greater changes in the level of consciousness.",
"   </p>",
"   <p>",
"    An altered level of consciousness indicates the need for immediate evaluation of the child's oxygenation, ventilation, and perfusion status. Signs of diminished perfusion to the brain include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Confusion",
"     </li>",
"     <li>",
"      Irritability",
"     </li>",
"     <li>",
"      Lethargy",
"     </li>",
"     <li>",
"      Agitation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Parents may be the first to recognize these signs but may be unable to describe them other than to say something is wrong. Failure of a child to recognize or respond to his or her parents or to respond to a painful stimulus is an ominous sign.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SKIN EXAMINATION AND CAPILLARY REFILL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The skin is a reliable organ for assessment of systemic perfusion because it is an indicator of systemic vascular resistance and the degree of shunting that is necessary to maintain blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The nail beds, mucous membranes, palms of the hands, and soles of the feet are pink and warm in a child with normal cardiorespiratory function.",
"     </li>",
"     <li>",
"      The skin may become cool, pale, mottled, or ashen if hypoxia or poor perfusion develops.",
"     </li>",
"     <li>",
"      Cooling of the skin begins peripherally and extends proximally when cardiac output decreases [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Capillary refill is a valuable initial physiologic parameter that can be evaluated more often than can other vital signs. The extremity should be lifted slightly above the level of the heart to ensure assessment of arteriolar capillary refill and not venous stasis. Light pressure is applied to blanch the fingernail bed. The pressure is released and the amount of time until color returns is measured. Normal is less than two seconds. Volume depletion or hypotension can delay capillary refill for more than three seconds [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/7\">",
"     7",
"    </a>",
"    ]. The usefulness of capillary refill is limited by interobserver variability and by the effect of environmental temperature [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/8\">",
"     8",
"    </a>",
"    ]. Prolongation of capillary refill can be induced in children with normal circulatory status by placing them in a cool environment such as an air-conditioned room [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PULSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of perfusion includes assessment of the rate, strength, and regularity of the central and peripheral pulses. The carotid, axillary, brachial, radial, femoral, dorsalis pedis, and posterior tibial pulses are readily palpable in healthy infants and children.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The carotid artery, on the side of the neck, is the most accessible artery to palpate in children older than one year of age.",
"     </li>",
"     <li>",
"      The short, chubby necks of children younger than one year of age render rapid location of the carotid artery difficult. Thus, palpation of the brachial artery is recommended in the rapid cardiopulmonary assessment of infants [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/2\">",
"       2",
"      </a>",
"      ]. Healthcare professionals also may palpate the femoral pulse.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The apical precordial impulse is not considered to be a \"pulse.\" Heart sounds that are heard over the apex of the heart represent electrical activity that may not be adequate to produce a perfusing pulse. Alternatively, the child's precordium may be quiet, and a precordial impulse may not be palpated despite the presence of satisfactory cardiac function and a strong central pulse [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Assessment of pulses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulses should be assessed bilaterally for volume, rate, and regularity. The volume of a pulse is related to pulse pressure, defined as the difference between systolic and diastolic blood pressure. The pulse pressure narrows when cardiac output decreases, rendering the pulse thready and difficult to feel. An exception may occur in early septic shock. Septic shock is a high cardiac output state characterized by a wide pulse pressure and bounding pulses caused by rapid runoff associated with systemic vasodilatation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A rapid pulse is a nonspecific clinical sign of distress and may result from stress (anxiety, pain, fear), fever, infection, medications, hypoxia, hypercapnia, hypovolemia, or cardiac impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/1,2,4,5\">",
"     1,2,4,5",
"    </a>",
"    ]. The development of bradycardia in a child with cardiorespiratory distress is a late sign, usually indicating that arrest is imminent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/2\">",
"     2",
"    </a>",
"    ]. The pulse rates in infants and children vary depending on age; familiarity with normal rates for age is needed to determine if a child requires a resuscitative intervention (",
"    <a class=\"graphic graphic_table graphicRef77057 \" href=\"UTD.htm?17/33/17947\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An irregular pulse usually is a warning of cardiac dysrhythmia. It is somewhat uncommon in previously healthy infants and children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Peripheral versus central pulses",
"    </span>",
"    &nbsp;&mdash;&nbsp;A discrepancy between central (carotid, brachial, femoral) and peripheral (radial, dorsalis pedis) pulses may be caused by vasoconstriction associated with a cold ambient temperature [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/8\">",
"     8",
"    </a>",
"    ] or it may be an early sign of decreased cardiac output and diminished peripheral perfusion.",
"   </p>",
"   <p>",
"    Absence of appreciable peripheral pulses does not always equate with cardiac arrest. Two studies have shown the difficulty that parents and laypersons have in identifying peripheral pulses in healthy children, even shortly after being taught to do so [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Even healthcare providers may over-diagnose pulselessness. Children with hypothermia or a prolonged arrest treated with high doses of vasopressors may not have palpable peripheral pulses despite return of spontaneous circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Absence of central pulses indicates ineffective or absent cardiac contractions and signifies the need for immediate resuscitative action.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     BLOOD PRESSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate blood pressure cuff size is essential for accurate blood pressure measurement. The inflatable rubber bladder should be long enough to encircle the entire circumference of the arm (overlap is acceptable) and should be wide enough to cover approximately 75 percent of the upper arm between the top of the shoulder and the olecranon. A cuff that is too narrow may result in a falsely elevated reading. Normal blood pressure values according to age are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef51186 \" href=\"UTD.htm?2/30/2540\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The median (50th percentile) systolic blood pressure for children older than one year can be approximated with following formula: 90 mmHg + (2 x age in years).",
"     </li>",
"     <li>",
"      The lower limit (5th percentile) of systolic blood pressure can be approximated with the following formula: 70 mmHg + (2 x age in years).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hypotension is a late finding in children with cardiopulmonary compromise, and heralds the onset of decompensated shock; even mild hypotension must be treated aggressively because cardiopulmonary arrest may be imminent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28948/abstract/2\">",
"     2",
"    </a>",
"    ]. The blood pressure of the child with compensated shock may be normal; signs of inadequate perfusion such as decreased level of consciousness, prolonged capillary refill, and tachycardia are typically observed before hypotension is seen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42901?source=see_link\">",
"     \"Physiology and classification of shock in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15723813\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rapid assessment of the adequacy of systemic perfusion is an essential part of pediatric resuscitation. It is accomplished by evaluation of mental status, capillary refill, pulses, and blood pressure. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Change in the level of consciousness of a child may indicate decreased cerebral oxygenation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      perfusion. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Mental status'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tachycardia and prolonged capillary refill are clinical manifestations of compensatory mechanisms designed to maintain a normal arterial perfusion pressure in the face of cardiopulmonary compromise. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Maintenance of cardiac output and perfusion pressure'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Skin examination and capillary refill'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A discrepancy between central (carotid, brachial, femoral) and peripheral (radial, dorsalis pedis) pulses may be an early sign of decreased cardiac output and diminished peripheral perfusion. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Peripheral versus central pulses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypotension is a late finding in children with cardiopulmonary compromise, and heralds the onset of decompensated shock; even mild hypotension must be treated aggressively because cardiopulmonary arrest may be imminent. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Blood pressure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Hazinski MF, Barkin RM. Shock. In: Pediatric Emergency Medicine: Concepts and Clinical Practice, 2nd, Barkin RM.  (Ed), Mosby, St. Louis 1997.",
"    </li>",
"    <li>",
"     Pediatric Advanced Life Support Provider Manual. Ralston M, et al (Eds), American Heart Association, Subcommittee on Pediatric Resuscitation, Dallas, 2006, p.61.",
"    </li>",
"    <li>",
"     Friedman WF. The intrinsic physiologic properties of the developing heart. In: Neonatal Heart Disease, Friedman WF.  (Ed), Grune and Stratton, New York 1973.",
"    </li>",
"    <li>",
"     American College of Surgeons, Committee on Trauma. Advanced trauma life support, 6th ed, American College of Surgeons, Chicago 1997.",
"    </li>",
"    <li>",
"     Ludwig S, Lavelle JM. Resuscitation-pediatric basic and advanced life support. In: Textbook of Pediatric Emergency Medicine, 5th, Fleisher GR, Ludwig S, Henretig FM.  (Eds), Lippincott, Williams &amp; Wilkins, Philadelphia 2006. p.3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28948/abstract/6\">",
"      Joly HR, Weil MH. Temperature of the great toe as an indication of the severity of shock. Circulation 1969; 39:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28948/abstract/7\">",
"      Baraff LJ. Capillary refill: is it a useful clinical sign? Pediatrics 1993; 92:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28948/abstract/8\">",
"      Gorelick MH, Shaw KN, Baker MD. Effect of ambient temperature on capillary refill in healthy children. Pediatrics 1993; 92:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28948/abstract/9\">",
"      Cavallaro DL, Melker RJ. Comparison of two techniques for detecting cardiac activity in infants. Crit Care Med 1983; 11:189.",
"     </a>",
"    </li>",
"    <li>",
"     Gillette PC, Garson A Jr, Porter CJ, McNamara DG. Dysrhythmias. In: Moss's Heart Disease in Infants, Children, and Adolescents, 4th, Adams FH, Emmanouilides GC, Riemenschneider TA.  (Eds), Williams &amp; Wilkins, Baltimore 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28948/abstract/11\">",
"      Kisting, M, Goetting, MG. The misdiagnosis of pediatric cardiac arrest: Pseudo-electromechanical dissociation in children. Acad Emerg Med 1994; 1:A87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28948/abstract/12\">",
"      Versmold HT, Kitterman JA, Phibbs RH, et al. Aortic blood pressure during the first 12 hours of life in infants with birth weight 610 to 4,220 grams. Pediatrics 1981; 67:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28948/abstract/13\">",
"      Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987; 79:1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6387 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-3548BCC041-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28948=[""].join("\n");
var outline_f28_17_28948=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15723813\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MAINTENANCE OF CARDIAC OUTPUT AND PERFUSION PRESSURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MENTAL STATUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SKIN EXAMINATION AND CAPILLARY REFILL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PULSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Assessment of pulses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Peripheral versus central pulses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      BLOOD PRESSURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15723813\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6387\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6387|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/56/8077\" title=\"figure 1\">",
"      Blood pressure algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/5/36957\" title=\"figure 2\">",
"      CV response hypovolemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6387|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/33/17947\" title=\"table 1\">",
"      Heart rates in normal children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/30/2540\" title=\"table 2\">",
"      Blood pressure children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/36/34375?source=related_link\">",
"      Clinical manifestations and diagnosis of edema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42901?source=related_link\">",
"      Physiology and classification of shock in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_17_28949="Overview of the management of the vasculitides in adults";
var content_f28_17_28949=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the management of the vasculitides in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28949/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28949/contributors\">",
"     Gene G Hunder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28949/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28949/contributors\">",
"     John H Stone, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28949/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28949/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/17/28949/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vasculitides are defined by the presence of leukocytes in the vessel wall with reactive damage to mural structures. In general, affected vessels vary in size, type, and location in association with the specific vasculitic disorder.",
"   </p>",
"   <p>",
"    The vasculitides are often serious and sometimes fatal diseases that require prompt recognition and therapy. Symptomatic involvement of affected organs may either occur in isolation or in combination with multiple organs. The distribution of affected organs may suggest a particular vasculitic disorder, but significant overlap is observed.",
"   </p>",
"   <p>",
"    Fortunately, available treatments are helpful, particularly in the acute phase. However, during maintenance therapy with corticosteroids and immunosuppressive agents, the adverse effects of drugs and superimposed infections may assume increasing importance. Mortality data suggest that, while early deaths in vasculitis are due to the active disease, late deaths may be due to the complications of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will provide an overview of the management of the vasculitides. The classification and diagnostic manifestations of the different vasculitides and an overview of the approach to the patient with suspected vasculitis are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/23/37241?source=see_link\">",
"     \"Classification of and approach to the vasculitides in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy depends upon the nature and severity of the vasculitis. The following discussion will only review general therapeutic themes. Exact recommendations concerning therapy in these disorders, including dosing regimens, are presented separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hypersensitivity vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;With a mild hypersensitivity vasculitis due to a drug reaction, discontinuing the offending drug may be adequate; an antihistamine might be used for itching associated with urticaria. A short course of corticosteroids may also be necessary for more severe cases. In addition, simple observation may be adequate for transitory vasculitis confined to the skin, as with mild cases of Henoch-Sch&ouml;nlein purpura (IgA vasculitis).",
"   </p>",
"   <p>",
"    In some instances, the cutaneous vasculitis is prolonged or becomes chronic, and it is not associated with any recognizable cause. In these patients, a nonsteroidal antiinflammatory drug may be appropriate for initial therapy. Drugs such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32983?source=see_link\">",
"     colchicine",
"    </a>",
"    , antihistamines, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32688?source=see_link\">",
"     dapsone",
"    </a>",
"    may also be helpful in selected cases and may be utilized prior to the administration of a more potent regimen of glucocorticoids or cytotoxic drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. In one study, colchicine was no more likely than placebo to lead to remission of leukocytoclastic vasculitis; however, disease recurrence as colchicine was withdrawn suggested a beneficial effect for some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Occasionally, combinations of these drugs (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32688?source=see_link\">",
"     dapsone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/28/13765?source=see_link\">",
"     pentoxifylline",
"    </a>",
"    ) are more effective than single therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/4\">",
"     4",
"    </a>",
"    ]. Patients with complicated disease that requires these newer or more toxic therapies should be referred to a rheumatologist for consultation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Systemic vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with systemic vasculitic involvement usually require at least glucocorticoid therapy. As an example, glucocorticoid therapy usually leads to remission in giant cell arteritis. In most patients, the dose can be reduced and eventually discontinued, but some require chronic therapy with low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/26/34217?source=see_link\">",
"     \"Treatment of giant cell (temporal) arteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By comparison, patients with rapidly progressive vasculitic diseases, such as granulomatosis with polyangiitis (Wegener&rsquo;s) or polyarteritis nodosa, are likely to require combination therapy consisting of a cytotoxic drug (usually",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ) and steroids. Both oral or pulse cyclophosphamide have been utilized based upon clinician experience and disease severity. After one or two months of combined therapy, the steroid dose may be reduced; therapy is usually continued for 6 to 12 months to diminish the risk of relapse.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     Azathioprine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    have been used in less severe forms of vasculitis and as maintenance therapy after remission has been induced by cyclophosphamide. Other drugs such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil and biologic agents appear to be useful in some instances.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATIENT MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once treatment has been initiated, patient monitoring relies upon some, but not all, of the procedures used in diagnosis. The goal of initial treatment is to induce remission of the disease. Once this has been accomplished, the drug dose is lowered to limit the induction of drug-induced toxicity. However, there are two long-term concerns: most forms of vasculitis (except for drug-induced hypersensitivity vasculitis) can relapse, and vascular injury during the acute phase can heal with scarring and narrowing of the affected vessels, potentially leading to signs of ischemia that do",
"    <strong>",
"     not",
"    </strong>",
"    reflect recurrent active disease. Thus, prolonged monitoring is indicated. It may be difficult at times to accurately determine whether a change in findings results from the disease, medications, or scarring.",
"   </p>",
"   <p>",
"    Monitoring may be facilitated by the utilization of standardized risk scores. These include the Vasculitis Activity Index for different types of systemic necrotizing vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/5\">",
"     5",
"    </a>",
"    ]; the Birmingham Vasculitis Activity Score, which has been modified for use in granulomatosis with polyangiitis (Wegener&rsquo;s) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]; and disease extent indices [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/32/34314?source=see_link&amp;anchor=H3#H3\">",
"     \"Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\", section on 'Assessment of disease activity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Symptoms and signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain symptoms and signs, such as headache, jaw claudication, skin lesions, and fever, are easily monitored. By comparison, others, such as symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    signs of mesenteric lesions in polyarteritis nodosa, are more difficult to detect.",
"   </p>",
"   <p>",
"    Even if the underlying vasculitis has abated, some manifestations, such as neuropathy, may take months to recede, while others may be permanent. As a result, the patient often needs extra support and encouragement during this period. Many patients have read lay or medical publications concerning vasculitis and become discouraged about their lack of rapid improvement and possible poor outcome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various different laboratory tests have been utilized to help monitor disease activity. Most, such as the erythrocyte sedimentation rate or the serum C-reactive protein concentration, are relatively nonspecific; however, the lack of specificity of these tests and other acute phase reactants limits their usefulness.",
"   </p>",
"   <p>",
"    In patients with granulomatosis with polyangiitis (Wegener&rsquo;s) or microscopic polyangiitis (microscopic polyarteritis), plasma ANCA titers, especially antiproteinase 3 antibodies (C-ANCA), usually parallel the course of the vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. In particular, the disappearance of ANCA is almost always associated with clinical remission [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/12\">",
"     12",
"    </a>",
"    ], and patients who maintain negative titers after therapy are at low risk for clinical relapse (5 and 17 percent in two studies) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once remission has been induced, it has been suggested by some that a rise in plasma ANCA titers is highly predictive of subsequent clinical relapse in patients with granulomatosis with polyangiitis (Wegener&rsquo;s). However, the lack of uniform predictability of clinical relapse has led most physicians",
"    <strong>",
"     not",
"    </strong>",
"    to initiate prophylactic therapy for ANCA titers alone. Such patients should be monitored carefully for clinical signs of active disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Radiographic studies and biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound examination and magnetic resonance imaging of areas of large-artery involvement may help follow progression and may reveal new areas of involvement. However, some tests used for diagnosis should be avoided, if possible, to reassess the patient. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If an arteriogram was performed as part of the diagnosis, a second examination is not usually necessary for follow-up, unless (perhaps) an operative intervention is planned.",
"     </li>",
"     <li>",
"      If a biopsy was diagnostic, little more is to be learned by repeating the procedure as part of monitoring.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These cautions do not apply, of course, if the patient's symptoms change dramatically for the worse or if a new illness is suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The limited data available reveal a surprisingly good outcome for many patients with vasculitis (",
"    <a class=\"graphic graphic_table graphicRef71697 \" href=\"UTD.htm?14/9/14491\">",
"     table 1",
"    </a>",
"    ). Most cases of pure hypersensitivity vasculitis resolve spontaneously, and appropriately treated patients with giant cell arteritis do not have an overall increased mortality relative to normals in the same older age group [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Henoch-Sch&ouml;nlein purpura (IgA vasculitis) resolves almost universally in all patients, although the course may be more severe in the few adults with this vasculitis. Overall outcome is good in both age groups with complete recovery observed in 94 and 89 percent of children and adults, respectively, in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Polyarteritis nodosa, one of the most worrisome vasculitides, is associated with a five-year survival rate of around 60 percent (much higher than initial reports of 13 percent in patients with untreated disease). Improved survival is observed among those with limited organ involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/18\">",
"     18",
"    </a>",
"    ]. Patients with granulomatosis with polyangiitis (Wegener&rsquo;s) who are treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    have a five-year survival of approximately 70 percent; most deaths were due either to complications of the vasculitis (cardiovascular disease or renal failure) or to complications that may have been due to therapy (infection or malignancy) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28949/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/22/44389?source=see_link\">",
"       \"Patient information: Vasculitis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19406963\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Therapy depends upon the nature and severity of the vasculitis. For example, with a mild hypersensitivity vasculitis due to a drug reaction, discontinuing the offending drug may be adequate, or observation alone may suffice for transitory vasculitis confined to the skin. Further treatment depends on the degree of severity and the extent of involvement and may include an antihistamine, a nonsteroidal antiinflammatory drug, a short or more sustained course of glucocorticoids, a cytotoxic agent, or other medications. Patients with systemic vasculitic disorders usually require at least glucocorticoid therapy, and some require cytotoxic agents or other immunosuppressives. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Therapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Hypersensitivity vasculitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Systemic vasculitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Monitoring of patients under treatment relies upon some of the procedures used in diagnosis and may be facilitated by the utilization of standardized risk scores. The goal of initial treatment is to induce remission of the disease; the drug dose is then lowered to limit drug-induced toxicity. Prolonged monitoring of signs, symptoms, and laboratory findings that characterize active disease in patients with a given diagnosis is required for prompt recognition of relapse and for evaluation of whether a change in findings results from the disease, medications, or scarring. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Patient monitoring'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Symptoms and signs'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Laboratory tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some imaging studies, such as ultrasound or magnetic resonance imaging, may be helpful for monitoring large vessel vasculitic involvement in selected patients, while repeat arteriography or biopsies that were used in diagnosis are generally avoided, unless a patient's symptoms change dramatically for the worse or unless a new illness is suspected. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Radiographic studies and biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Disease outcome varies, depending on the disorder (",
"      <a class=\"graphic graphic_table graphicRef71697 \" href=\"UTD.htm?14/9/14491\">",
"       table 1",
"      </a>",
"      ). It is especially good for most patients with pure hypersensitivity vasculitis, giant cell arteritis, or Henoch-Sch&ouml;nlein purpura (IgA vasculitis). By contrast, polyarteritis nodosa and granulomatosis with polyangiitis (Wegener&rsquo;s) have five-year survival rates of 60 and 70 percent, respectively. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/1\">",
"      Villa-Forte A, European League Against Rheumatism, European Vasculitis Study Group. European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis. Curr Opin Rheumatol 2010; 22:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/2\">",
"      Sais G, Vidaller A, Jucgl&agrave; A, et al. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol 1995; 131:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/3\">",
"      Winkelmann RK, Wilson-Jones E, Smith NP, et al. Neutrophilic urticaria. Acta Derm Venereol 1988; 68:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/4\">",
"      N&uuml;rnberg W, Grabbe J, Czarnetzki BM. Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol 1995; 75:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/5\">",
"      Whiting-O'Keefe QE, Stone JH, Hellmann DB. Validity of a vasculitis activity index for systemic necrotizing vasculitis. Arthritis Rheum 1999; 42:2365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/6\">",
"      Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/7\">",
"      Stone JH, Hoffman GS, Merkel PA, et al. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 2001; 44:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/8\">",
"      Mahr AD, Neogi T, Lavalley MP, et al. Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis. Arthritis Rheum 2008; 59:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/9\">",
"      Basu N, Watts R, Bajema I, et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010; 69:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/10\">",
"      Reinhold-Keller E, Kekow J, Schnabel A, et al. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994; 37:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/11\">",
"      de Groot K, Gross WL. Wegener's granulomatosis: disease course, assessment of activity and extent and treatment. Lupus 1998; 7:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/12\">",
"      Geffriaud-Ricouard C, No&euml;l LH, Chauveau D, et al. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 1993; 39:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/13\">",
"      Pettersson E, Heigl Z. Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study. Clin Nephrol 1992; 37:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/14\">",
"      Jayne DR, Gaskin G, Pusey CD, Lockwood CM. ANCA and predicting relapse in systemic vasculitis. QJM 1995; 88:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/15\">",
"      G&ouml;bel U, Eichhorn J, Kettritz R, et al. Disease activity and autoantibodies to endothelial cells in patients with Wegener's granulomatosis. Am J Kidney Dis 1996; 28:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/16\">",
"      Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996; 100:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/17\">",
"      Blanco R, Mart&iacute;nez-Taboada VM, Rodr&iacute;guez-Valverde V, et al. Henoch-Sch&ouml;nlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 1997; 40:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/18\">",
"      Ribi C, Cohen P, Pagnoux C, et al. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients. Arthritis Rheum 2010; 62:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28949/abstract/19\">",
"      Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. Am J Med 1996; 101:129.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8224 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.25.216.6-3A7D25EF8E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28949=[""].join("\n");
var outline_f28_17_28949=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19406963\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hypersensitivity vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Systemic vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATIENT MONITORING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Radiographic studies and biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19406963\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/8224\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8224|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/9/14491\" title=\"table 1\">",
"      Survival in vasculitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/23/37241?source=related_link\">",
"      Classification of and approach to the vasculitides in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/32/34314?source=related_link\">",
"      Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/22/44389?source=related_link\">",
"      Patient information: Vasculitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/26/34217?source=related_link\">",
"      Treatment of giant cell (temporal) arteritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_17_28950="HHV-6 encephalitis MRI 3";
var content_f28_17_28950=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F77735&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F77735&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 540px\">",
"   <div class=\"ttl\">",
"    MRI findings of HHV-6 encephalitis in hematopoietic cell transplant recipients",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 520px; height: 400px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Magnetic resonance imaging of the brain for the&nbsp;4 patients who developed limbic encephalitis, showing axial images at the level of the basal ganglia. Arrows indicate signal hyperintensities in the region of the hippocampus. Shown are T2-weighted imaging (A) and diffusion imaging (B) for patient 1, on day +21 after stem cell transplantation (SCT), 6 days after onset of neurological symptoms. (C) T2-weighted fluid attenuated inversion recovery imaging for patient 2 on day +24 after SCT, on the day of onset of neurological symptoms. (D) T2-weighted imaging for patient 3 on day +40 after SCT, 20 days after onset of neurological symptoms. (E) T2-weighted imaging for patient 4 on day +43 after SCT, 10 days after onset of neurological symptoms.",
"    <div class=\"footnotes\">",
"     MRI: magnetic resonance imaging; HHV-6: human herpesvirus 6",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ogata, M, Kikuchi, H, Satou, T, et al. Human Herpesvirus 6 DNA in Plasma after Allogeneic Stem Cell Transplantation: Incidence and Clinical Significance. J Infect Dis 2006; 193:68. Copyright &copy;2006 University of Chicago Press.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.journals.uchicago.edu/\">",
"      file://www.journals.uchicago.edu/",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28950=[""].join("\n");
var outline_f28_17_28950=null;
var title_f28_17_28951="Definition and etiology of fever in neonates and infants (less than three months of age)";
var content_f28_17_28951=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Definition and etiology of fever in neonates and infants (less than three months of age)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28951/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28951/contributors\">",
"     Hannah F Smitherman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28951/contributors\">",
"     Charles G Macias, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28951/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28951/contributors\">",
"     Stephen J Teach, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28951/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28951/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28951/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/17/28951/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever is a prominent symptom of many different disease processes. Neonates and young infants may manifest fever as the only sign of significant underlying infection. The incidence of serious bacterial infection (SBI) is higher in infants less than three months of age, particularly those under 28 days, than at any other time in childhood. In addition, these young patients can experience significant morbidity from some viral infections.",
"   </p>",
"   <p>",
"    This topic will review the definition and etiology of fever in the neonate and young infant less than three months of age. Strategies that have been developed to evaluate febrile children in this age group, as well as the evaluation and management of fever in neonates and infants less than three months of age and in infants and children age three to 36 months are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/38/40550?source=see_link\">",
"     \"Strategies for the evaluation of fever in neonates and infants (less than three months of age)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link\">",
"     \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/14/22762?source=see_link\">",
"     \"Fever without a source in children 3 to 36 months of age\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION OF FEVER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rectal temperatures are the standard for detecting fever in infants less than three months of age and the majority of studies establishing the risk of serious infections in febrile young infants have relied upon rectal temperatures. A rectal temperature of 38&ordm;C (100.4&ordm;F) generally is regarded as fever in the neonate 0 to 28 days of age. The definition of fever in the one- to three-month-old varies from 38 to 38.2&ordm;C (100.4 to 100.7&ordm;F) depending on the study cited and on local custom [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/38/40550?source=see_link&amp;anchor=H2#H2\">",
"     \"Strategies for the evaluation of fever in neonates and infants (less than three months of age)\", section on 'Traditional strategies'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    Axillary, temporal artery and tympanic membrane temperatures are unreliable in young infants when compared to rectal thermometry as the gold standard but may be used when rectal thermometry is contraindicated, such as in patients with neutropenia, bleeding diathesis (eg, thrombocytopenia), or necrotizing enterocolitis. Glass thermometers should not be used. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18570?source=see_link&amp;anchor=H703490142#H703490142\">",
"     \"Pathophysiology and management of fever in infants and children\", section on 'Temperature measurement'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Caregiver report of fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not uncommon for caregivers to report an elevated temperature in an infant who is afebrile at the time of evaluation. A history of objective fever by rectal temperature requires evaluation even if the infant is afebrile at the time of presentation. On the other hand, an afebrile infant with a reported history of subjective fever only who has not had antipyretic therapy and who looks well and has no suspicious findings on history or physical examination may avoid laboratory testing. However, this should only occur when reliable follow-up can be arranged, rectal temperature can be monitored at home, and parents understand indications to seek medical consultation.",
"   </p>",
"   <p>",
"    As an example, in a study of 292 infants younger than two months of age with a history of fever who were admitted to the hospital for possible sepsis, caretakers reported fever by rectal thermometer in 244 infants and tactile fever in 48 infants [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/4\">",
"     4",
"    </a>",
"    ]. The following were findings in a retrospective review of outcomes of these children:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Of 244 infants with reported fever per rectum, 224 (92 percent) had fever on presentation or during the subsequent 48 hours of hospitalization. In contrast, 22 of 48 infants (46 percent) with reported tactile fever had fever on presentation or during the subsequent 48 hours of hospitalization.",
"     </li>",
"     <li>",
"      Of 26 infants with tactile fever who were afebrile on presentation, none had subsequent fever during hospitalization, and one had a serious bacterial infection (urinary tract infection).",
"     </li>",
"     <li>",
"      Of 40 infants with reported fever per rectum who were afebrile on presentation, eight (20 percent) had subsequent fever during hospitalization, and four (10 percent) had serious bacterial infection. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Serious bacterial infection'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Among the 19 infants with serious bacterial infection (five of whom were afebrile on presentation), all exhibited abnormal clinical",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      laboratory features on evaluation that were suggestive of underlying serious infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This study was conducted shortly after the licensing of Haemophilus influenzae type b vaccine and prior to the introduction of the heptavalent pneumococcal vaccine. The fact that these patients differ with respect to current immunization practice and the possible benefit derived from herd immunity limits interpretation of these findings in a modern-day population where the etiologies of SBI and the invasiveness of the related pathogens have shifted significantly. This uncertainty increases the importance of the clinical assessment and assurance of reliable follow-up.",
"   </p>",
"   <p>",
"    However, in a study of infants seen in community settings, cases of bacteremia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bacterial meningitis, although rare, were documented among infants with normal temperatures in the office but fever at home by rectal thermometer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Bundling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bundling of infants in clothing or blankets generally causes an elevation in skin temperature rather than rectal temperature [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/6\">",
"     6",
"    </a>",
"    ]. However, in a study of newborns who were bundled and had rectal temperatures measured over the next 2.5 hours, 2 of 12 infants reached a temperature of 38&ordm;C [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/7\">",
"     7",
"    </a>",
"    ]. Nevertheless, a minimally elevated rectal temperature should rarely, if ever, be attributed to bundling. In addition, a fever &gt;38.5&ordm;C (101&ordm;F) should not be attributed to bundling regardless of the manner taken.",
"   </p>",
"   <p>",
"    When overbundling is \"suspect\" as a cause for an elevated temperature, the child may be unbundled and the temperature retaken rectally in 15 to 30 minutes. The infant can be considered afebrile if the repeat temperature is normal and the infant remains well-appearing and has not received antipyretic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/6\">",
"     6",
"    </a>",
"    ]. Parental education and follow-up with the primary care provider are essential in this circumstance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     IMMUNOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The immunologic competence of the neonate and young infant improves steadily in the first three months of life. The developing fetus has T and B lymphocytes at an early gestational age, but the development of immunologic function must be modulated to coexist with the mother's immune system. The newborn's immunologic task switches abruptly at birth from this coexistent state (graft preservation) to protection from invading pathogens.",
"   </p>",
"   <p>",
"    At birth, T and B lymphocytes are present in numbers similar to or exceeding adult levels. However, the function of these cells in the newborn is diminished in areas such as mitogen-induced proliferation (T cells) and ability to induce immunoglobulin synthesis (B cells). Levels of the infant's own IgG increase steadily in the first few months of life as maternal levels decrease. Neutrophils also are present at early stages of gestation but differ in functional capacity from adult neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=see_link\">",
"     \"The humoral immune response\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/12/16585?source=see_link\">",
"     \"Immunity of the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This immune system development explains the vulnerability to different types of infectious diseases at varying ages within the first three months of life. Very young infants are more susceptible to serious bacterial infection than older infants. This susceptibility is related to the decline of maternal antibody at a time when the infant's antibody production is beginning to increase and the child has not yet been immunized against pneumococcus and Haemophilus influenzae type b (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Bacterial pathogens'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    A more detailed discussion of newborn immunology is found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31242?source=see_link\">",
"     \"The development of immune cells in the fetus and neonate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/12/16585?source=see_link\">",
"     \"Immunity of the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY OF FEVER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology, adaptive value, and treatment of fever are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18570?source=see_link\">",
"     \"Pathophysiology and management of fever in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability to generalize data from prior studies is limited in that many of these prospective and retrospective studies were conducted in an era where numerous vaccines that are now included in routine childhood immunizations were unavailable (eg, pneumococcal conjugate vaccine, Haemophilus influenza type b vaccine,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/5/12374?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/29/33237?source=see_link\">",
"     rotavirus vaccine",
"    </a>",
"    ). Additionally, the Advisory Committee on Immunization Practices recommends influenza vaccine administration for all children &ge;6 months [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/9\">",
"     9",
"    </a>",
"    ]. While vaccination for influenza does not directly impact the youngest infants, older children serve as the most effective vectors of disease transmission in the community. Consequently, the epidemiology of influenza in the youngest infants is likely to be changed by the vaccination of older children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Viral infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral infection is the most common cause of fever in this age group. In a study of infants 28 days or younger, a subgroup of 960 neonates with fever 17 percent had identifiable viral infections and 14 percent had a SBI [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/10\">",
"     10",
"    </a>",
"    ]. In contrast, a prospective study of 1779 febrile infants 1 to 90 days of life identified viral pathogens in 35 percent of the cohort versus bacterial pathogens in 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The neonate acquires infection through vertical transmission and postnatally from sources such as family members and hospital personnel. Neonates and young infants are more likely than older infants to experience morbidity from a viral infection, in part because of a decreased responsiveness of T cell-mediated immunity. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Immunology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Viruses that can cause serious illness in this age group include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Herpes simplex (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=see_link\">",
"       \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Varicella (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4278?source=see_link\">",
"       \"Varicella-zoster infection in the newborn\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Enteroviruses (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link\">",
"       \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Influenza virus (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Some adenoviruses (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=see_link\">",
"       \"Epidemiology and clinical manifestations of adenovirus infection\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Respiratory syncytial virus (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link\">",
"       \"Respiratory syncytial virus infection: Clinical features and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Serious bacterial infection",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Definition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the studies of fever in the neonate and young infant define outcomes by the occurrence of serious bacterial infection (SBI). In most studies, SBIs are defined as bacteremia, bacterial meningitis, bacterial pneumonia, skin and soft tissue infections, osteomyelitis, bacterial gastroenteritis, septic arthritis, or urinary tract infection. Although not classically described in the literature of the early 1990s, the attention to community-acquired Staphylococcus aureus has made pustulosis a relevant disease entity to be considered in skin and soft tissue infections in neonates [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of SBI in the neonate and young infant is difficult to quantify due to the variability in definitions of fever provided in the literature. Nevertheless, a meta-analysis of studies published between 1974 and 1990 found that 7 percent of all febrile infants (&gt;39&ordm;C or 102.2&ordm;F) under three months of age had an SBI, and bacteremia or bacterial meningitis occurred in 2.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/13\">",
"     13",
"    </a>",
"    ]. A higher incidence of these illnesses occurred in infants in the first month of life (8.7 and 3.7 percent, respectively).",
"   </p>",
"   <p>",
"    Two studies performed after the introduction of vaccination against Haemophilus influenza, type b found a higher prevalence of SBI (12 to 13 percent) in febrile neonates under 29 days of age [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An observational study during the time period after introduction of routine vaccination with heptavalent pneumococcal vaccine demonstrates a rate of 12.8 percent in infants 1 to 90 days with fever (18.8 percent in children &le;28 days and 11.3 percent in infants &gt;28 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/16\">",
"     16",
"    </a>",
"    ]. That the introduction of the heptavalent pneumococcal vaccine has decreased the rates of bacteremia is evident in an observational cohort study that identified children three years of age or younger and included 50 immunized and 67 unimmunized children 0 to 90 days of age. In this cohort, the rates of SBI were significantly higher among unimmunized children. Moreover, there were no cases of pneumococcal bacteremia in any of the infants who had received at least one dose of heptavalent pneumococcal vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hyperpyrexia is rare among febrile infants younger than three months. However, one observational study found that the 98 infants (under three months of age) with temperature &ge;40&ordm;C had a 29 percent absolute increase in prevalence of SBI (38 versus 9 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Bacterial pathogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Escherichia coli and Group B streptococcus are the pathogens most likely to cause bacteremia and bacterial meningitis in febrile young infants younger than three months of age. Escherichia coli also cause the majority of urinary tract infections in this age group. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H6#H6\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Pathogenesis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H11#H11\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/47/26360?source=see_link&amp;anchor=H6#H6\">",
"     \"Epidemiology and risk factors for urinary tract infections in children\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although of much lower prevalence, Listeria monocytogenes also is a notable bacterial pathogen in neonates as it is still an important although uncommon cause of bacterial meningitis, especially in neonates younger than 28 days of age and premature infants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link\">",
"     \"Clinical features and diagnosis of bacterial meningitis in the neonate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/44/1736?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Listeria monocytogenes infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other potential etiologies of serious bacterial illness in febrile young infants include Staphylococcus aureus, Streptococcus pneumoniae, Salmonella species, Enterococcus faecalis, Enterobacter cloacae, Moraxella catarrhalis, Klebsiella species, and Citrobacter species [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Of these, Staphylococcus aureus is the most frequent isolate from skin and soft tissue infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/36/4680?source=see_link&amp;anchor=H4#H4\">",
"     \"Mastitis and breast abscess in infants, children, and adolescents\", section on 'Neonatal mastitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=see_link&amp;anchor=H7#H7\">",
"     \"Skin abscesses, furuncles, and carbuncles\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Sources of infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;UTI accounts for most SBI in infants under 90 days of age; being seen in up to 73 percent of febrile infants with SBI in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/21\">",
"     21",
"    </a>",
"    ]. Bacteremia, cellulitis, meningitis, and pneumonia comprise other important sources of infection (",
"    <a class=\"graphic graphic_table graphicRef50729 \" href=\"UTD.htm?10/63/11259\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/11,21\">",
"     11,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study from the Pediatric Research in Office Settings (PROS) network described rates of SBI among 3066 infants ages three months and younger, who were evaluated in the primary care office setting rather than the emergency department [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/5\">",
"     5",
"    </a>",
"    ]. The incidence of both bacteremia and bacterial meningitis decreased with increasing age:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      3 and 1.1 percent, respectively, in infants zero to one month of age",
"     </li>",
"     <li>",
"      1.4 and 0.4 percent in infants greater than one to two months of age",
"     </li>",
"     <li>",
"      0.7 and 0 percent in infants greater than two to three months of age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Urinary tract infection (UTI) was common in the cohort overall, occurring in 19 percent of uncircumcised boys, 13 percent of girls, and 17 percent of infants of either gender with prolonged illness. These numbers are likely underestimates, as only slightly more than 50 percent of infants had a urine test.",
"   </p>",
"   <p>",
"    The significance of the urinary tract as a source of SBI in febrile young infants was further substantiated in a large prospective study of 1025 infants &le;60 days of age, who were evaluated for fever &ge;38&ordm;C in eight pediatric emergency departments [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/22\">",
"     22",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among infants with fever &ge;39&ordm;C, 16 percent had a UTI, in comparison to 7 percent of other infants.",
"     </li>",
"     <li>",
"      UTI was diagnosed in 21 percent of uncircumcised males and in 9 percent of infants overall.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk of UTI in uncircumcised male infants is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/47/26360?source=see_link&amp;anchor=H8#H8\">",
"     \"Epidemiology and risk factors for urinary tract infections in children\", section on 'Host factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Salmonella is a consideration in young infants with fever, particularly in those who also have diarrhea or blood in the stool. A relatively small percent of these infants will have associated bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28951/abstract/23\">",
"     23",
"    </a>",
"    ]. Salmonella meningitis occurs rarely in young infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/40/40578?source=see_link\">",
"       \"Patient information: Fever in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/23/37235?source=see_link\">",
"       \"Patient information: Fever in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever may be the only sign of significant underlying infection in neonates and young infants. The following points regarding the definition and etiology of fever in this age group are important to consider:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fever in neonates and infants less than three months of age is defined as a rectal temperature &ge;38&ordm;C (100.4&ordm;F). Rectal temperatures are the standard for detecting fever in infants less than three months of age and the majority of studies establishing the risk of serious infections in febrile young infants have relied upon rectal temperatures. Axillary, temporal artery, and tympanic membrane temperatures are unreliable in young infants but may be used when rectal thermometry is contraindicated, such as in patients with neutropenia, bleeding diathesis (eg, thrombocytopenia), or necrotizing enterocolitis. Glass thermometers should",
"      <strong>",
"       not",
"      </strong>",
"      be used. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition of fever'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A reliable caretaker report of fever should be carefully evaluated, even if the infant is afebrile at presentation. We suggest that a thorough history and physical examination be performed in all such infants. The temperature should be repeated after a brief period of observation. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Caregiver report of fever'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bundling can cause a minimal elevation in rectal temperature. Fever may be attributed to bundling in the infant with no history of fever, who appears well, has a normal physical examination, and whose rectal temperature is &lt;38.4&ordm;C after unbundling. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Bundling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Viral infections are the most common cause of fever in neonates and young infants. Viruses that can cause significant infection include herpes simplex, varicella, enteroviruses, influenza virus, some adenoviruses, and respiratory syncytial virus. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Viral infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The common bacterial pathogens that cause significant infection in infants younger then three months of age include Escherichia coli (bacteremia, meningitis, and UTI), Group B streptococcus (bacteremia and meningitis), and Staphylococcus aureus (skin and soft tissue infections). Listeria monocytogenes also is a notable bacterial pathogen in neonates as it is still an important although uncommon cause of bacterial meningitis, especially in neonates younger than 28 days of age and premature infants. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Bacterial pathogens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sources of serious bacterial infection (SBI) among neonates and infants less than three months of age are urinary tract infections, bacteremia, bacterial gastroenteritis, bacterial meningitis, and skin or soft tissue infections. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Sources of infection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/1\">",
"      Dagan R, Sofer S, Phillip M, Shachak E. Ambulatory care of febrile infants younger than 2 months of age classified as being at low risk for having serious bacterial infections. J Pediatr 1988; 112:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/2\">",
"      Baraff LJ. Management of the febrile child: a survey of pediatric and emergency medicine residency directors. Pediatr Infect Dis J 1991; 10:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/3\">",
"      Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med 1993; 22:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/4\">",
"      Anbar RD, Richardson-de Corral V, O'Malley PJ. Difficulties in universal application of criteria identifying infants at low risk for serious bacterial infection. J Pediatr 1986; 109:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/5\">",
"      Pantell RH, Newman TB, Bernzweig J, et al. Management and outcomes of care of fever in early infancy. JAMA 2004; 291:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/6\">",
"      Grover G, Berkowitz CD, Lewis RJ, et al. The effects of bundling on infant temperature. Pediatrics 1994; 94:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/7\">",
"      Cheng TL, Partridge JC. Effect of bundling and high environmental temperature on neonatal body temperature. Pediatrics 1993; 92:238.",
"     </a>",
"    </li>",
"    <li>",
"     Williams C, Cole FS. Immunology of the fetus and newborn. In: Avery's Diseases of the Newborn, 8th, Taeush H, Ballard R, Gleason C.  (Eds), Elsevier Saunders, Philadelphia 2005. p.447.",
"    </li>",
"    <li>",
"     ACIP provisional recommendations for the use of influenza vaccines. Available at: www.cdc.gov/vaccines/recs/provisional/downloads/flu-vac-mar-2010-508.pdf (Accessed on May 25, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/10\">",
"      Caviness AC, Demmler GJ, Almendarez Y, Selwyn BJ. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 2008; 153:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/11\">",
"      Byington CL, Enriquez FR, Hoff C, et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics 2004; 113:1662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/12\">",
"      Fortunov RM, Hulten KG, Hammerman WA, et al. Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. Pediatrics 2007; 120:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/13\">",
"      Baskin MN. The prevalence of serious bacterial infections by age in febrile infants during the first 3 months of life. Pediatr Ann 1993; 22:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/14\">",
"      Kadish HA, Loveridge B, Tobey J, et al. Applying outpatient protocols in febrile infants 1-28 days of age: can the threshold be lowered? Clin Pediatr (Phila) 2000; 39:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/15\">",
"      Baker MD, Bell LM. Unpredictability of serious bacterial illness in febrile infants from birth to 1 month of age. Arch Pediatr Adolesc Med 1999; 153:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/16\">",
"      Maniaci V, Dauber A, Weiss S, et al. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 2008; 122:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/17\">",
"      Carstairs KL, Tanen DA, Johnson AS, et al. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine. Ann Emerg Med 2007; 49:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/18\">",
"      Stanley R, Pagon Z, Bachur R. Hyperpyrexia among infants younger than 3 months. Pediatr Emerg Care 2005; 21:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/19\">",
"      Byington CL, Rittichier KK, Bassett KE, et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics 2003; 111:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/20\">",
"      Greenhow TL, Hung YY, Herz AM. Changing epidemiology of bacteremia in infants aged 1 week to 3 months. Pediatrics 2012; 129:e590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/21\">",
"      Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med 1993; 329:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/22\">",
"      Zorc JJ, Levine DA, Platt SL, et al. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Pediatrics 2005; 116:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28951/abstract/23\">",
"      Torrey S, Fleisher G, Jaffe D. Incidence of Salmonella bacteremia in infants with Salmonella gastroenteritis. J Pediatr 1986; 108:718.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6073 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-095FD25BCF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28951=[""].join("\n");
var outline_f28_17_28951=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION OF FEVER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Caregiver report of fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Bundling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      IMMUNOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOPHYSIOLOGY OF FEVER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Viral infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Serious bacterial infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Definition",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Incidence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Bacterial pathogens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Sources of infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6073\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6073|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/63/11259\" title=\"table 1\">",
"      Sources of infection in febrile young infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=related_link\">",
"      Clinical features and diagnosis of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=related_link\">",
"      Clinical features and diagnosis of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/44/1736?source=related_link\">",
"      Clinical manifestations and diagnosis of Listeria monocytogenes infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=related_link\">",
"      Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=related_link\">",
"      Epidemiology and clinical manifestations of adenovirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/47/26360?source=related_link\">",
"      Epidemiology and risk factors for urinary tract infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=related_link\">",
"      Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/14/22762?source=related_link\">",
"      Fever without a source in children 3 to 36 months of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=related_link\">",
"      Group B streptococcal infection in neonates and young infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/12/16585?source=related_link\">",
"      Immunity of the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/36/4680?source=related_link\">",
"      Mastitis and breast abscess in infants, children, and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=related_link\">",
"      Neonatal herpes simplex virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18570?source=related_link\">",
"      Pathophysiology and management of fever in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/23/37235?source=related_link\">",
"      Patient information: Fever in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/40/40578?source=related_link\">",
"      Patient information: Fever in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=related_link\">",
"      Skin abscesses, furuncles, and carbuncles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/38/40550?source=related_link\">",
"      Strategies for the evaluation of fever in neonates and infants (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31242?source=related_link\">",
"      The development of immune cells in the fetus and neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=related_link\">",
"      The humoral immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4278?source=related_link\">",
"      Varicella-zoster infection in the newborn",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_17_28952="Extragenital lichen sclerosus";
var content_f28_17_28952=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Extragenital lichen sclerosus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28952/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28952/contributors\">",
"     Heidi Jacobe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28952/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28952/contributors\">",
"     Jeffrey Callen, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28952/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28952/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/17/28952/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 5, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1945208\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lichen sclerosus (also known as lichen sclerosus et atrophicus) is a chronic inflammatory disorder characterized by the presence of porcelain white, atrophic plaques on the skin. Most cases of lichen sclerosus involve the female genitalia; extragenital manifestations occur in a minority of patients.",
"   </p>",
"   <p>",
"    The epidemiology, clinical manifestations, and treatment of extragenital lichen sclerosus will be reviewed here. Anogenital lichen sclerosus is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/45/6874?source=see_link\">",
"     \"Vulvar lichen sclerosus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14872?source=see_link&amp;anchor=H16#H16\">",
"     \"Balanitis and balanoposthitis in adults\", section on 'Lichen sclerosus or balanitis xerotica obliterans'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1945215\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extragenital manifestations are estimated to occur in approximately 15 to 20 percent of patients with lichen sclerosus [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/1\">",
"     1",
"    </a>",
"    ]. Similar to genital lichen sclerosus, extragenital disease appears to be more common in women than in men. In a retrospective review, 17 out of 20 patients with histopathologic findings consistent with extragenital lichen sclerosus were female [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/2\">",
"     2",
"    </a>",
"    ]. The disorder is rare in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1945222\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of lichen sclerosus is not well understood, and most information on this subject has been derived from studies in genital disease. Proposed etiologic factors for lichen sclerosus have included immune dysfunction, genetic predisposition, infectious agents, and trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/3-12\">",
"     3-12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/45/6874?source=see_link&amp;anchor=H3#H3\">",
"     \"Vulvar lichen sclerosus\", section on 'Etiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1945229\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extragenital lichen sclerosus can occur in any location on the skin and infrequently appears in the oral cavity. Concomitant vulvar or penile lichen sclerosus may or may not be present. Conjunctival lesions do not occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704587\">",
"    <span class=\"h2\">",
"     Cutaneous lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extragenital lesions are most commonly found on the back, shoulder, neck, wrist, thigh, and inframammary areas [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/1,13\">",
"     1,13",
"    </a>",
"    ]. Disease following the lines of Blaschko (",
"    <a class=\"graphic graphic_figure graphicRef57219 \" href=\"UTD.htm?31/60/32710\">",
"     figure 1",
"    </a>",
"    ) also has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Early skin lesions of lichen sclerosus often appear as flat-topped and slightly scaly, hypopigmented, white, or mildly erythematous polygonal papules that may coalesce to form larger plaques (",
"    <a class=\"graphic graphic_picture graphicRef58815 graphicRef70580 graphicRef70084 \" href=\"UTD.htm?30/44/31434\">",
"     picture 1A-C",
"    </a>",
"    ). Over time, lesions develop a porcelain white color, variable degrees of palpable sclerosis, and a cigarette paper-like wrinkled appearance that correlates with epidermal atrophy (",
"    <a class=\"graphic graphic_picture graphicRef74154 graphicRef79867 graphicRef60332 \" href=\"UTD.htm?14/47/15098\">",
"     picture 2A-C",
"    </a>",
"    ). In individuals with dark skin, established lesions may demonstrate hyperpigmentation and hypopigmentation rather than a porcelain white color (",
"    <a class=\"graphic graphic_picture graphicRef51592 graphicRef59300 \" href=\"UTD.htm?22/51/23353\">",
"     picture 3A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/16\">",
"     16",
"    </a>",
"    ]. Peripheral erythema, telangiectasias, follicular keratotic plugs, and hemorrhagic or nonhemorrhagic bullae may also be present (",
"    <a class=\"graphic graphic_picture graphicRef79659 \" href=\"UTD.htm?31/57/32663\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Extragenital lichen sclerosus is usually asymptomatic. However, occasional patients experience pruritus or painful fissuring, particularly when lesions are located in areas subject to friction or tension, such as the inframammary folds, antecubital fossae, axillae, waist, inguinal creases, and popliteal fossae. In addition, trauma to unaffected skin, such as injury from tight clothing, injections, radiation therapy, herpes zoster, or other factors precipitate new lesions in some patients (Koebner phenomenon) (",
"    <a class=\"graphic graphic_picture graphicRef72972 \" href=\"UTD.htm?26/47/27380\">",
"     picture 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/11,12,19,20\">",
"     11,12,19,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704594\">",
"    <span class=\"h2\">",
"     Oral lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral lichen sclerosus is a rare manifestation of this disorder that involves the lips, gingiva, palate, tongue or buccal mucosa in children and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/21-24\">",
"     21-24",
"    </a>",
"    ]. Lesions often appear as irregular white or hypopigmented plaques. Most patients are asymptomatic, but occasional patients experience pruritus, burning, or tightness in affected areas [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/21,22,25\">",
"     21,22,25",
"    </a>",
"    ]. Oral lesions may present independently or in association with lichen sclerosus in other sites [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/26\">",
"     26",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704608\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of extragenital lichen sclerosus can often be made based upon the clinical appearance of lesions. When the diagnosis is uncertain, such as when features suggestive of other disorders are also present, a punch biopsy is useful for confirming the diagnosis. (See",
"    <a class=\"local\" href=\"#H704623\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40264?source=see_link&amp;anchor=H12#H12\">",
"     \"Skin biopsy techniques\", section on 'Punch biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The characteristic pathological features of lichen sclerosus include (",
"    <a class=\"graphic graphic_picture graphicRef58841 \" href=\"UTD.htm?8/37/8789\">",
"     picture 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epidermal hyperkeratosis with follicular plugging",
"     </li>",
"     <li>",
"      Epidermal atrophy with flattening of rete ridges",
"     </li>",
"     <li>",
"      Vacuolization of the basal layer of the epidermis",
"     </li>",
"     <li>",
"      Marked edema in the superficial dermis (early lesions)",
"     </li>",
"     <li>",
"      Homogenized collagen in the upper dermis (established lesions)",
"     </li>",
"     <li>",
"      Lymphohistiocytic infiltrate underlying the zone of homogenized collagen",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The identification of these histopathologic findings in lesions suspicious for lichen sclerosus is almost always indicative of the diagnosis. Although similar histopathologic findings occur in the lichen sclerosus-like variant of chronic graft-versus-host disease, the clinical history facilitates the differentiation of these disorders (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/5/42073?source=see_link&amp;anchor=H3566637#H3566637\">",
"     \"Cutaneous manifestations of graft-versus-host disease (GVHD)\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H704623\">",
"     'Differential diagnosis'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704623\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of disorders may present with clinical features that resemble extragenital lichen sclerosus. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Vitiligo &ndash;",
"      </strong>",
"      Vitiligo is characterized by the presence of well-demarcated depigmented patches on the skin (",
"      <a class=\"graphic graphic_picture graphicRef74712 graphicRef63623 \" href=\"UTD.htm?6/57/7063\">",
"       picture 7A-B",
"      </a>",
"      ). In contrast to lichen sclerosus, skin texture is normal, without signs of atrophy or sclerosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21193?source=see_link\">",
"       \"Vitiligo\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Lichen planus &ndash;",
"      </strong>",
"      Lichen sclerosus may present as polygonal papules on the wrists or ankles that closely resemble lichen planus (",
"      <a class=\"graphic graphic_picture graphicRef76383 graphicRef63590 \" href=\"UTD.htm?33/58/34727\">",
"       picture 8A-B",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/27,28\">",
"       27,28",
"      </a>",
"      ]. Unlike lichen sclerosus, lichen planus often is pruritic. A skin biopsy can be used to distinguish between these disorders. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/27/9656?source=see_link\">",
"       \"Lichen planus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Tinea versicolor &ndash;",
"      </strong>",
"      Tinea versicolor presents with hypopigmented macules and patches primarily located on the trunk and proximal upper extremities (",
"      <a class=\"graphic graphic_picture graphicRef72396 graphicRef73839 \" href=\"UTD.htm?27/9/27801\">",
"       picture 9A-B",
"      </a>",
"      ). Fine scale is often evident and a potassium hydroxide preparation will reveal the presence of fungal elements. Signs of cutaneous atrophy and sclerosis are absent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3320?source=see_link\">",
"       \"Tinea versicolor\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/51/31543?source=see_link&amp;anchor=H4044416#H4044416\">",
"       \"Dermatologic procedures\", section on 'Potassium hydroxide (KOH) prep'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Anetoderma &ndash;",
"      </strong>",
"      In anetoderma, loss of elastin in the dermis contributes to reduced skin elasticity and the appearance of circumscribed, 1 to 3 cm areas of depressed, flaccid, wrinkled, or bulging skin (",
"      <a class=\"graphic graphic_picture graphicRef67581 \" href=\"UTD.htm?33/36/34369\">",
"       picture 10",
"      </a>",
"      ). Anetoderma may occur as a primary disorder or as a result of a preceding inflammatory process or other skin abnormality. The neck, trunk, and upper extremities are most frequently affected.",
"     </li>",
"     <li>",
"      <strong>",
"       Cutaneous T-cell lymphoma &ndash;",
"      </strong>",
"      Like lichen sclerosus, lesions of patch stage mycosis fungoides may present with epidermal atrophy manifesting as fine cigarette paper-like wrinkling (",
"      <a class=\"graphic graphic_picture graphicRef60650 graphicRef63888 \" href=\"UTD.htm?20/13/20696\">",
"       picture 11A-B",
"      </a>",
"      ). Lesions of mycosis fungoides are often erythematous, resembling an eczematous dermatitis.",
"      <strong>",
"      </strong>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides\", section on 'Skin lesions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Chronic graft versus host disease &ndash;",
"      </strong>",
"      Patients who have received hematopoietic cell transplants may develop lesions that closely resemble extragenital lichen sclerosus as a manifestation of chronic graft-versus-host disease. Knowledge of the patient&rsquo;s transplant history is useful for diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/5/42073?source=see_link&amp;anchor=H877766#H877766\">",
"       \"Cutaneous manifestations of graft-versus-host disease (GVHD)\", section on 'Sclerotic manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Morphea",
"      </strong>",
"      &ndash; Clinical findings consistent with extragenital lichen sclerosus may occur in patients with morphea (",
"      <a class=\"graphic graphic_picture graphicRef82529 graphicRef53986 \" href=\"UTD.htm?24/14/24805\">",
"       picture 12A-B",
"      </a>",
"      ). The relationship between these disorders is controversial. It is unclear whether the appearance of lesions consistent with lichen sclerosus represents the simultaneous occurrence of two separate disorders or the development of clinical findings that simply resemble lichen sclerosus in lesions of morphea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/8/133?source=see_link\">",
"       \"Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1945250\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few data on the efficacy of treatments for extragenital lichen sclerosus. Recommendations for the use of specific agents are primarily based upon case reports, small uncontrolled studies, and data from studies in genital disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20076616\">",
"    <span class=\"h2\">",
"     Approach to treatment of skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extragenital lichen sclerosus is a benign, often asymptomatic condition; thus, the decision to proceed with therapy is often based upon the patient&rsquo;s desire for treatment. Deferring treatment is a reasonable option, particularly for patients with limited skin involvement. Common reasons for initiating treatment include symptomatic, cosmetically distressing, extensive, or progressively worsening disease.",
"   </p>",
"   <p>",
"    Topical medications, phototherapy, and systemic agents have been used for the treatment of extragenital lichen sclerosus; however, data on the efficacy of these treatments are limited. Topical corticosteroids are typically used as initial therapy due to their consistent efficacy in genital lichen sclerosus, reports of clinical experience documenting improvement in patients with extragenital lesions, and the ease of administration and relative safety of these agents. Other topical medications that have been associated with improvement in individual patients include topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    and topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/54/5988?source=see_link\">",
"     calcipotriol",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    In the setting of widespread disease, application of topical corticosteroids to all lesions often is impractical. Phototherapy may be used for these patients. Phototherapy is also an option for the treatment of patients with disease that is refractory to topical corticosteroids.",
"   </p>",
"   <p>",
"    Systemic therapy is rarely utilized for extragenital lichen sclerosus due to the relative paucity of efficacy data and the potential for severe adverse effects. Treatment with systemic agents is primarily reserved for patients with severe disease that has failed to respond to other treatments.",
"   </p>",
"   <p>",
"    Providing patients with realistic expectations for treatment outcomes is an additional important component of patient management. Although symptoms and the appearance and texture of lesions can improve with treatment, lesions usually do not completely resolve. In our experience, early lesions are most likely to respond to therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704636\">",
"    <span class=\"h2\">",
"     First line therapies",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704651\">",
"    <span class=\"h3\">",
"     Topical corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the efficacy of topical corticosteroids in extragenital lichen sclerosus has not been formally studied, improvement in genital disease during topical corticosteroid therapy has been reported in a randomized treatment comparison trial as well as uncontrolled and retrospective studies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/29-32\">",
"     29-32",
"    </a>",
"    ]. Multiple reports of clinical experience documenting successful treatment of extragenital lichen sclerosus with superpotent topical corticosteroids also support the use of these agents for this disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/13,17,27,33-36\">",
"     13,17,27,33-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We typically prescribe once daily application of a superpotent agent, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"     clobetasol",
"    </a>",
"    propionate (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/13\">",
"     13",
"    </a>",
"    ]. Clinical experience suggests topical corticosteroids are less consistently effective for extragenital lesions than for genital lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/13\">",
"     13",
"    </a>",
"    ], and if there is no improvement after two months, or if adverse effects are noted, we discontinue treatment and consider alternative therapies. Topical corticosteroids may also be used as an adjunctive treatment in patients receiving phototherapy or systemic therapy.",
"   </p>",
"   <p>",
"    Potential adverse effects of topical corticosteroid therapy include local cutaneous atrophy and systemic absorption resulting in suppression of the hypothalamic-pituitary axis. Hypothalamic-pituitary axis suppression is most likely to occur with the use of high potency agents or during treatment of large areas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=see_link&amp;anchor=H16#H16\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704783\">",
"    <span class=\"h3\">",
"     Phototherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phototherapy offers the ability to treat large areas of skin, thereby facilitating the treatment of patients with widespread lesions. We also use phototherapy as an alternative treatment for patients with more limited disease who have failed treatment with topical corticosteroids.",
"   </p>",
"   <p>",
"    The mechanism through which phototherapy improves lichen sclerosus is unknown, but may involve factors such as the stimulation of matrix metalloproteinases and the depletion of proinflammatory cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/37\">",
"     37",
"    </a>",
"    ]. Additional studies are necessary to determine whether exposure of uninvolved skin during phototherapy prevents the development of new lesions.",
"   </p>",
"   <p>",
"    Several forms of phototherapy have been used for the management of lichen sclerosus. The largest study involved the treatment of 10 patients with 40 sessions of ultraviolet A1 (UVA1) light at a dose of 20",
"    <span class=\"nowrap\">",
"     J/cm",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    four times per week [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/38\">",
"     38",
"    </a>",
"    ]. All patients exhibited lesion softening and improvement in pigmentation. In addition, a few case reports have documented marked improvements in disease severity following treatment with narrowband ultraviolet B (UVB) light [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/33,37\">",
"     33,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Psoralen plus ultraviolet A light (PUVA) involves the administration of an oral or topical photosensitizer (psoralen) prior to light treatment. Oral PUVA was effective in a patient who failed to respond to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"     clobetasol",
"    </a>",
"    propionate and topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/39\">",
"     39",
"    </a>",
"    ]. Oral PUVA also was used successfully in combination with topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    in a separate patient [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/40\">",
"     40",
"    </a>",
"    ]. The need for strict photoprotection following the oral administration of psoralens makes PUVA treatment less favorable than other forms of phototherapy for some patients.",
"   </p>",
"   <p>",
"    Adverse effects of phototherapy include burning or blistering of skin and potential increased risks for premature skin aging and cutaneous malignancy. The risk for malignancy appears to be highest with long-term PUVA treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44457?source=see_link&amp;anchor=H14#H14\">",
"     \"Management of severe refractory atopic dermatitis (eczema)\", section on 'Psoralen plus UVA'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704934\">",
"    <span class=\"h2\">",
"     Other therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other treatments reported to be effective in small numbers of patients include topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    alone [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/41\">",
"     41",
"    </a>",
"    ], topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/54/5988?source=see_link\">",
"     calcipotriol",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/42\">",
"     42",
"    </a>",
"    ], pulsed dye laser [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/43,44\">",
"     43,44",
"    </a>",
"    ], photodynamic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/44\">",
"     44",
"    </a>",
"    ], and carbon dioxide laser vaporization [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/45\">",
"     45",
"    </a>",
"    ]. Topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/41/29332?source=see_link\">",
"     pimecrolimus",
"    </a>",
"    , which has been used successfully for vulvar disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/29\">",
"     29",
"    </a>",
"    ], was not effective in one patient with extragenital lichen sclerosus [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/46\">",
"     46",
"    </a>",
"    ]. Additional studies are necessary to determine the efficacies of these treatments for extragenital disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H705066\">",
"    <span class=\"h2\">",
"     Refractory severe disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic immunosuppressive therapy is rarely used for the management of lichen sclerosus. It is a treatment option for severe disease in patients who have failed to respond to topical corticosteroids and phototherapy or who are unable to receive phototherapy. We typically treat these patients with a combination of systemic glucocorticoids and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The efficacy of glucocorticoids plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    is supported by a retrospective study of seven patients with progressively worsening extragenital lichen sclerosus that failed to respond to a potent topical corticosteroid (all patients) and phototherapy (six patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/47\">",
"     47",
"    </a>",
"    ]. Patients were treated with 15 mg per week of methotrexate and 1000 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    sodium succinate on three consecutive days per month. Treatment was continued for six months in six patients and for 10 months in one patient who had a delayed response to treatment. A significant decrease in a non-validated clinical disease severity score was detected at the end of treatment. In most patients, signs of improvement were first noted after three months of therapy.",
"   </p>",
"   <p>",
"    Our typical treatment regimen includes 10 to 20 mg per week of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    plus oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day or 40 to 60 mg per day). We aim to taper the systemic glucocorticoid within the first three to six months of therapy, and begin the taper once disease progression has ceased, erythema has resolved, and lesion improvement is noted. The optimum duration of therapy with methotrexate is not established. We generally maintain patients on the lowest effective dose, tapering over time as tolerated.",
"   </p>",
"   <p>",
"    Monotherapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    has also been used successfully in a patient with extragenital disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/48\">",
"     48",
"    </a>",
"    ]. We generally reserve initial treatment with methotrexate alone for patients who have slow disease progression or who are poor candidates for systemic glucocorticoid therapy.",
"   </p>",
"   <p>",
"    A variety of potential of adverse effects are associated with treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    and glucocorticoids. Use of methotrexate is contraindicated in pregnancy, and relative contraindications for methotrexate therapy include alcohol abuse and preexisting liver disease. Dose adjustments of methotrexate are necessary in patients with renal insufficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11223?source=see_link\">",
"     \"Major side effects of low-dose methotrexate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The efficacy of other systemic therapies that have been used in genital lichen sclerosus (eg, oral retinoids,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ) for extragenital disease is unknown. Improvement in extragenital lichen sclerosus complicated by bullae and ulceration during",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    therapy was reported in one patient [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20076853\">",
"    <span class=\"h2\">",
"     Treatment of oral lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of oral lesions of lichen sclerosus often is not required, and is usually only initiated in the setting of cosmetic concerns or symptoms. Treatments that have been associated with improvement in this disorder include superpotent or medium potency topical corticosteroids [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/23,50\">",
"     23,50",
"    </a>",
"    ], intralesional corticosteroid injections (10",
"    <span class=\"nowrap\">",
"     mg/cc",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    acetonide) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/51\">",
"     51",
"    </a>",
"    ], topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/26\">",
"     26",
"    </a>",
"    ], topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/41/29332?source=see_link\">",
"     pimecrolimus",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/25\">",
"     25",
"    </a>",
"    ], topical corticosteroids followed by topical testosterone [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/52\">",
"     52",
"    </a>",
"    ], surgical excision [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/22\">",
"     22",
"    </a>",
"    ], oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32983?source=see_link\">",
"     colchicine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/22\">",
"     22",
"    </a>",
"    ], and oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/61/6102?source=see_link\">",
"     griseofulvin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1014337\">",
"    <span class=\"h2\">",
"     Morphea with lichen sclerosus features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with morphea who present with coexisting lesions consistent with lichen sclerosus should be managed similar to other morphea patients. (See",
"    <a class=\"local\" href=\"#H704623\">",
"     'Differential diagnosis'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/14/17640?source=see_link\">",
"     \"Treatment of morphea (localized scleroderma) in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40985?source=see_link&amp;anchor=H17#H17\">",
"     \"Localized scleroderma in childhood\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H705439\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of extragenital lichen sclerosus has been poorly characterized. In our experience, the disease process often continues over the course of years, with unpredictable periods of exacerbation and stability.",
"   </p>",
"   <p>",
"    Unlike genital lichen sclerosus, extragenital lichen sclerosus is not considered a risk factor for squamous cell carcinoma (SCC). However, reports of the development of SCC in sites of cutaneous lesions in two patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28952/abstract/54,55\">",
"     54,55",
"    </a>",
"    ] suggest that extragenital lichen sclerosus might stimulate the development of cutaneous SCC in rare patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/12/14530?source=see_link\">",
"       \"Patient information: Lichen sclerosus (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1014499\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Extragenital lichen sclerosus is an uncommon disorder that may involve the skin or oral cavity. The disorder occurs more frequently in women than in men, and the occurrence in children is rare. (See",
"      <a class=\"local\" href=\"#H1945215\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early skin lesions of lichen sclerosus often present as flat-topped polygonal papules that may coalesce into large plaques (",
"      <a class=\"graphic graphic_picture graphicRef58815 graphicRef70580 graphicRef70084 \" href=\"UTD.htm?30/44/31434\">",
"       picture 1A-C",
"      </a>",
"      ). Mature lesions frequently develop a porcelain-white color, a finely wrinkled surface, and variable degrees of sclerosis (",
"      <a class=\"graphic graphic_picture graphicRef74154 graphicRef79867 graphicRef60332 \" href=\"UTD.htm?14/47/15098\">",
"       picture 2A-C",
"      </a>",
"      ). In individuals with dark skin, lesions may be hyperpigmented or hypopigmented (",
"      <a class=\"graphic graphic_picture graphicRef51592 graphicRef59300 \" href=\"UTD.htm?22/51/23353\">",
"       picture 3A-B",
"      </a>",
"      ). Oral lichen sclerosus presents as irregular white or hypopigmented plaques on the lips or in the oral cavity. (See",
"      <a class=\"local\" href=\"#H1945229\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A variety of other skin disorders share clinical features with lichen sclerosus. When the diagnosis is uncertain based upon clinical examination, a skin biopsy should be performed. (See",
"      <a class=\"local\" href=\"#H704608\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H704623\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Extragenital lichen sclerosus is a benign condition, and treatment may be deferred by patients who do not desire intervention. Common indications for proceeding with therapy include symptomatic, cosmetically distressing, extensive, or progressively worsening disease. (See",
"      <a class=\"local\" href=\"#H20076616\">",
"       'Approach to treatment of skin lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with limited extragenital lichen sclerosus who desire treatment, we suggest treatment with a superpotent topical corticosteroid such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"       clobetasol",
"      </a>",
"      propionate (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H704651\">",
"       'Topical corticosteroids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with widespread lesions, in whom application of topical therapy is impractical, or for patients who fail treatment with a superpotent topical corticosteroid, we suggest treatment with ultraviolet A1 (UVA1) phototherapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If UVA1 phototherapy is not available, patients may be treated with narrowband ultraviolet B (UVB) or psoralen plus ultraviolet A (PUVA). (See",
"      <a class=\"local\" href=\"#H704783\">",
"       'Phototherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with severe disease that fails to respond to topical corticosteroids and phototherapy, we suggest treatment with a combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      (10 to 20 mg given on a weekly basis) and systemic glucocorticoids (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Other systemic treatments that have been reported to be effective in single patients include methotrexate alone and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"       hydroxychloroquine",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H705066\">",
"       'Refractory severe disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/1\">",
"      Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353:1777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/2\">",
"      Carlson JA, Lamb P, Malfetano J, et al. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol 1998; 11:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/3\">",
"      Sander CS, Ali I, Dean D, et al. Oxidative stress is implicated in the pathogenesis of lichen sclerosus. Br J Dermatol 2004; 151:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/4\">",
"      Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol 1995; 33:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/5\">",
"      Weide B, Walz T, Garbe C. Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol 2000; 142:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/6\">",
"      Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144:1432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/7\">",
"      Chan I, Oyama N, Neill SM, et al. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Clin Exp Dermatol 2004; 29:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/8\">",
"      Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003; 362:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/9\">",
"      Oyama N, Chan I, Neill SM, et al. Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J Clin Invest 2004; 113:1550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/10\">",
"      Kowalewski C, Kozowska A, Chan I, et al. Three-dimensional imaging reveals major changes in skin microvasculature in lipoid proteinosis and lichen sclerosus. J Dermatol Sci 2005; 38:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/11\">",
"      Anderton RL, Abele DC. Lichen sclerosus et atrophicus in a vaccination site. Arch Dermatol 1976; 112:1787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/12\">",
"      Yates VM, King CM, Dave VK. Lichen sclerosus et atrophicus following radiation therapy. Arch Dermatol 1985; 121:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/13\">",
"      Neill SM, Lewis FM, Tatnall FM, et al. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010; 163:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/14\">",
"      Libow LF, Coots NV. Lichen sclerosus following the lines of Blaschko. J Am Acad Dermatol 1998; 38:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/15\">",
"      Choi SW, Yang JE, Park HJ, Kim CW. A case of extragenital lichen sclerosus following Blaschko's lines. J Am Acad Dermatol 2000; 43:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/16\">",
"      Farris DR, Hardy D, Kagen MH, et al. Extragenital pigmented lichen sclerosus. J Eur Acad Dermatol Venereol 2000; 14:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/17\">",
"      Ballester I, Ba&ntilde;uls J, P&eacute;rez-Crespo M, Lucas A. Extragenital bullous lichen sclerosus atrophicus. Dermatol Online J 2009; 15:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/18\">",
"      Garrido-R&iacute;os AA, Alvarez-Garrido H, Sanz-Mu&ntilde;oz C, et al. Dermoscopy of extragenital lichen sclerosus. Arch Dermatol 2009; 145:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/19\">",
"      Forschner A, Metzler G, Rassner G, Fierlbeck G. Morphea with features of lichen sclerosus et atrophicus at the site of a herpes zoster scar: another case of an isotopic response. Int J Dermatol 2005; 44:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/20\">",
"      Noakes RR, Spelman L. K&ouml;bnerization in a woman with generalized lichen sclerosus. Australas J Dermatol 2004; 45:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/21\">",
"      Attili VR, Attili SK. Lichen sclerosus of lips: a clinical and histopathologic study of 27 cases. Int J Dermatol 2010; 49:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/22\">",
"      Azevedo RS, Roma&ntilde;ach MJ, de Almeida OP, et al. Lichen sclerosus of the oral mucosa: clinicopathological features of six cases. Int J Oral Maxillofac Surg 2009; 38:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/23\">",
"      Kelly SC, Helm KF, Zaenglein AL. Lichen sclerosus of the lip. Pediatr Dermatol 2006; 23:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/24\">",
"      Jensen T, Worsaae N, Melgaard B. Oral lichen sclerosus et atrophicus: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/25\">",
"      Kim CY, Kim JG, Oh CW. Treatment of oral lichen sclerosus with 1% pimecrolimus cream. Ann Dermatol 2010; 22:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/26\">",
"      Wakamatsu J, Yamamoto T, Uchida H, Tsuboi R. Lichen sclerosus et atrophicus of the lip: successful treatment with topical tacrolimus. J Eur Acad Dermatol Venereol 2008; 22:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/27\">",
"      V&aacute;zquez MG, Navarra R, Martin-Urda MT, et al. Lichen Sclerosus et Atrophicus with Cutaneous Distribution Simulating Lichen Planus. Case Rep Dermatol 2010; 2:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/28\">",
"      Corbal&aacute;n-V&eacute;lez R, P&eacute;rez-Ferriols A. Lichen sclerosus et atrophicus affecting the wrists and left ankle and clinically simulating lichen planus. Cutis 2001; 67:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/29\">",
"      Goldstein AT, Creasey A, Pfau R, et al. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J Am Acad Dermatol 2011; 64:e99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/30\">",
"      Ayhan A, Guven S, Guvendag Guven ES, et al. Topical testosterone versus clobetasol for vulvar lichen sclerosus. Int J Gynaecol Obstet 2007; 96:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/31\">",
"      Lorenz B, Kaufman RH, Kutzner SK. Lichen sclerosus. Therapy with clobetasol propionate. J Reprod Med 1998; 43:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/32\">",
"      Dalziel KL, Millard PR, Wojnarowska F. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol 1991; 124:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/33\">",
"      Colbert RL, Chiang MP, Carlin CS, Fleming M. Progressive extragenital lichen sclerosus successfully treated with narrowband UV-B phototherapy. Arch Dermatol 2007; 143:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/34\">",
"      Chen JF, Chiang CP, Chen YF. Bilateral zosteriform extragenital lichen sclerosus et atrophicus: a new clinical presentation. J Dermatol 2010; 37:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/35\">",
"      Bergstrom KG, Mengden SJ, Kamino H, Ramsay D. Extragenital lichen sclerosus et atrophicus. Dermatol Online J 2008; 14:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/36\">",
"      Marren P, De Berker D, Millard P, Wojnarowska F. Bullous and haemorrhagic lichen sclerosus with scalp involvement. Clin Exp Dermatol 1992; 17:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/37\">",
"      Kreuter A, Gambichler T. Narrowband UV-B phototherapy for extragenital lichen sclerosus. Arch Dermatol 2007; 143:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/38\">",
"      Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol 2002; 46:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/39\">",
"      Dalmau J, Baselga E, Ro&eacute; E, Alomar A. Psoralen-UVA treatment for generalized prepubertal extragenital lichen sclerosus et atrophicus. J Am Acad Dermatol 2006; 55:S56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/40\">",
"      Valdivielso-Ramos M, Bueno C, Hernanz JM. Significant improvement in extensive lichen sclerosus with tacrolimus ointment and PUVA. Am J Clin Dermatol 2008; 9:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/41\">",
"      Hengge UR, Krause W, Hofmann H, et al. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 2006; 155:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/42\">",
"      Kreuter A, Gambichler T, Sauermann K, et al. Extragenital lichen sclerosus successfully treated with topical calcipotriol: evaluation by in vivo confocal laser scanning microscopy. Br J Dermatol 2002; 146:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/43\">",
"      Greve B, Hartschuh W, Raulin C. [Extragenital lichen sclerosus et atrophicus - treatment with pulsed dye laser]. Hautarzt 1999; 50:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/44\">",
"      Passeron T, Lacour JP, Ortonne JP. Comparative treatment of extragenital lichen sclerosus with methylaminolevulinic Acid pulsed dye laser-mediated photodynamic therapy or pulsed dye laser alone. Dermatol Surg 2009; 35:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/45\">",
"      Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J Dermatol 1997; 136:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/46\">",
"      Arican O, Ciralik H, Sasmaz S. Unsuccessful treatment of extragenital lichen sclerosus with topical 1% pimecrolimus cream. J Dermatol 2004; 31:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/47\">",
"      Kreuter A, Tigges C, Gaifullina R, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate treatment in patients with refractory generalized extragenital lichen sclerosus. Arch Dermatol 2009; 145:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/48\">",
"      Nayeemuddin F, Yates VM. Lichen sclerosus et atrophicus responding to methotrexate. Clin Exp Dermatol 2008; 33:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/49\">",
"      Wakelin SH, James MP. Extensive lichen sclerosus et atrophicus with bullae and ulceration--improvement with hydroxychloroquine. Clin Exp Dermatol 1994; 19:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/50\">",
"      Rajlawat BP, Triantafyllou A, Field EA, Parslew R. Lichen sclerosus of the lip and buccal mucosa. Clin Exp Dermatol 2004; 29:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/51\">",
"      Buajeeb W, Kraivaphan P, Punyasingh J, Laohapand P. Oral lichen sclerosus et atrophicus. A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/52\">",
"      Brown AR, Dunlap CL, Bussard DA, Lask JT. Lichen sclerosus et atrophicus of the oral cavity: report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/53\">",
"      Macleod RI, Soames JV. Lichen sclerosus et atrophicus of the oral mucosa. Br J Oral Maxillofac Surg 1991; 29:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/54\">",
"      Sergeant A, Vernall N, Mackintosh LJ, et al. Squamous cell carcinoma arising in extragenital lichen sclerosus. Clin Exp Dermatol 2009; 34:e278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28952/abstract/55\">",
"      Sotillo Gago I, Mart&iacute;nez Sahuquillo A, Matilla A, Garc&iacute;a P&eacute;rez A. [Spinocellular epithelioma following scleroatrophic autoaneous licher]. Actas Dermosifiliogr 1977; 68:219.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15838 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.211.0.116-07B700FC44-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28952=[""].join("\n");
var outline_f28_17_28952=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1014499\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1945208\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1945215\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1945222\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1945229\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H704587\">",
"      Cutaneous lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H704594\">",
"      Oral lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H704608\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H704623\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1945250\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20076616\">",
"      Approach to treatment of skin lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H704636\">",
"      First line therapies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H704651\">",
"      - Topical corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H704783\">",
"      - Phototherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H704934\">",
"      Other therapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H705066\">",
"      Refractory severe disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20076853\">",
"      Treatment of oral lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1014337\">",
"      Morphea with lichen sclerosus features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H705439\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1014499\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/15838\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15838|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/60/32710\" title=\"figure 1\">",
"      Lines of Blaschko",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15838|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/30/35297\" title=\"picture 1A\">",
"      Lichen slcerosus papules and plaques on wrist",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/29/24020\" title=\"picture 1B\">",
"      Lichen sclerosus on the wrist",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/53/6999\" title=\"picture 1C\">",
"      Lichen sclerosus papules on the chest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/37/27216\" title=\"picture 2A\">",
"      Lichen sclerosus - trunk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/28/26052\" title=\"picture 2B\">",
"      Lichen sclerosus on the breast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/9/29844\" title=\"picture 2C\">",
"      Lichen sclerosus on the chest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/13/8404\" title=\"picture 3A\">",
"      Extragenital lichen sclerosus in dark skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/48/33541\" title=\"picture 3B\">",
"      Lichen sclerosus on the wrists in dark skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/57/32663\" title=\"picture 4\">",
"      Lichen sclerosus follicular plugging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/47/27380\" title=\"picture 5\">",
"      Lichen sclerosus in sites of friction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/37/8789\" title=\"picture 6\">",
"      Lichen sclerosus - histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/31/35312\" title=\"picture 7A\">",
"      Vitiligo - elbow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/54/37730\" title=\"picture 7B\">",
"      Vitiligo - hands",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/42/29346\" title=\"picture 8A\">",
"      Lichen planus wrists fair skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/29/18898\" title=\"picture 8B\">",
"      Lichen planus flexures dark skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/23/19827\" title=\"picture 9A\">",
"      Tinea versicolor back",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/9/20630\" title=\"picture 9B\">",
"      Tinea versicolor shoulder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/36/34369\" title=\"picture 10\">",
"      Anetoderma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/36/35393\" title=\"picture 11A\">",
"      Mycosis fungoides patches",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/16/40196\" title=\"picture 11B\">",
"      Mycosis fungoides poikiloderma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/5/90\" title=\"picture 12A\">",
"      Morphea and lichen sclerosus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/36/9793\" title=\"picture 12B\">",
"      Morphea with features of lichen sclerosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15838|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/56/39809\" title=\"table 1\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14872?source=related_link\">",
"      Balanitis and balanoposthitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/5/42073?source=related_link\">",
"      Cutaneous manifestations of graft-versus-host disease (GVHD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/51/31543?source=related_link\">",
"      Dermatologic procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/27/9656?source=related_link\">",
"      Lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40985?source=related_link\">",
"      Localized scleroderma in childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11223?source=related_link\">",
"      Major side effects of low-dose methotrexate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44457?source=related_link\">",
"      Management of severe refractory atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/8/133?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/12/14530?source=related_link\">",
"      Patient information: Lichen sclerosus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40264?source=related_link\">",
"      Skin biopsy techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3320?source=related_link\">",
"      Tinea versicolor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/14/17640?source=related_link\">",
"      Treatment of morphea (localized scleroderma) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21193?source=related_link\">",
"      Vitiligo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/45/6874?source=related_link\">",
"      Vulvar lichen sclerosus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_17_28953="Atopic dermatitis infant 2";
var content_f28_17_28953=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F77386%7EALLRG%2F77457%7EALLRG%2F56461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F77386%7EALLRG%2F77457%7EALLRG%2F56461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atopic dermatitis - infantile",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 325px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyperpigmented patches are present on the face of this infant with atopic dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atopic dermatitis: infantile",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 419px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Confluent erythema, microvesiculation, scaling, and crusting on the face, with similar involvement (to a lesser degree) on the trunk and arms. The facial involvement is more severe due to easier access to scratching; the baby is squeezing the breast skin to relieve the intense pruritus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fitzpatrick, TB, Johnson, RA, Wolff, K, et al (Eds). Color Atlas and Synopsis of Clinical Dermatology, 3rd ed, McGraw-Hill, New York, 1997. Copyright &copy; McGraw-Hill.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atopic dermatitis: infantile",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 328px; height: 447px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Confluent erythema, mircovesiculation, papules, crust, and scale of a young Asian infant; the shoulders are relatively spared, being protected from scratching by clothing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fitzpatrick, TB, Johnson, RA, Wolff, K, et al (Eds). Color Atlas and Synopsis of Clinical Dermatology, 3rd ed, McGraw-Hill, New York, 1997. Copyright &copy; McGraw-Hill.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28953=[""].join("\n");
var outline_f28_17_28953=null;
var title_f28_17_28954="Factors that modify breast cancer risk in women";
var content_f28_17_28954=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Factors that modify breast cancer risk in women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28954/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28954/contributors\">",
"     Mary E Costanza, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28954/contributors\">",
"     Wendy Y Chen, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28954/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28954/contributors\">",
"     Julie R Gralow, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/17/28954/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/17/28954/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/17/28954/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Globally, breast cancer is the most frequently diagnosed malignancy and the leading cause of cancer death in women. As an example, breast cancer is the most common cancer in females in the United States and the second most common cause of cancer death in women. About one-half of newly diagnosed breast cancers can be explained by known risk factors, such as age at menarche, first live birth, menopause, and proliferative breast disease. An additional 10 percent are associated with a positive family history. In addition, risk may be modified by demographic, lifestyle, and environmental factors, although their association with breast cancer risk has not been clearly demonstrated.",
"   </p>",
"   <p>",
"    This topic will review factors that modify breast cancer risk in women. Risk factors for male breast cancer and a specific discussion of risk factors for hormone receptor-negative, human epidermal growth factor 2 (HER2) negative breast cancer are discussed separately. Screening for breast cancer and risk prediction models that can help tailor screening recommendations for breast cancer are also discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/49/10009?source=see_link\">",
"       \"Clinical features, diagnosis, and staging of newly diagnosed breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/36/26186?source=see_link\">",
"       \"Breast cancer in men\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34441?source=see_link\">",
"       \"Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/49/41754?source=see_link\">",
"       \"Screening for breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/51/2872?source=see_link\">",
"       \"Risk prediction models for breast cancer screening\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33001831\">",
"    <span class=\"h1\">",
"     STANDARD RISK FACTORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Increasing age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of breast cancer increases with older age and peaks in the sixth decade. Using data from the Surveillance, Epidemiology, and End Results (SEER) database, the incidence of breast cancer by age range was [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      20 to 34 years of age &ndash; 2 percent",
"     </li>",
"     <li>",
"      35 to 44 years &ndash; 10 percent",
"     </li>",
"     <li>",
"      45 to 54 years &ndash; 23 percent",
"     </li>",
"     <li>",
"      55 to 64 years &ndash; 24 percent",
"     </li>",
"     <li>",
"      65 to 74 years &ndash; 20 percent",
"     </li>",
"     <li>",
"      75 to 84 years &ndash; 16 percent",
"     </li>",
"     <li>",
"      Age 85 and older &ndash; 6 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2354324740\">",
"    <span class=\"h2\">",
"     Female gender",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast cancer occurs 100 times more frequently in women than in men. In the United States, over 200,000 women are diagnosed with invasive breast cancer each year, compared to approximately 2000 cases that occur annually in men [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     White race",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, the highest rate of breast cancer occurs among white women, although breast cancer remains the most common cancer among women of every major ethnic group (",
"    <a class=\"graphic graphic_table graphicRef52691 \" href=\"UTD.htm?21/33/22043\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef67236 \" href=\"UTD.htm?28/41/29342\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Using data from population based cancer registries affiliated with the National Program of Cancer Registries and SEER, the rate of newly diagnosed breast cancer (per 100,000 women) was 122 and 117 for white and black women, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/5\">",
"     5",
"    </a>",
"    ]. Despite this, black women more commonly presented with regional or advanced disease (45 versus 35 percent) and had a 41 percent higher breast cancer specific mortality rate (32 versus 22 deaths per 100,000 women).",
"   </p>",
"   <p>",
"    Much of the ethnic differences in breast cancer rates are attributable to factors associated with lifestyle (eg, body mass index [BMI], reproductive patterns) and access to healthcare, although genetic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    biologic factors may also contribute [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. For example, breast cancer in women under 40 years old and triple-negative breast cancers appear to be more common among African Americans, than whites [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9303004\">",
"    <span class=\"h2\">",
"     Weight",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity (defined as a BMI &gt;30",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    is associated with an overall increase in morbidity and mortality. However, the risk of breast cancer associated with BMI appears to depend on the menopausal status of women. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=see_link\">",
"     \"Health hazards associated with obesity in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9303037\">",
"    <span class=\"h3\">",
"     Postmenopausal women",
"    </span>",
"    &nbsp;&mdash;&nbsp;A higher BMI",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    weight gain have been consistently associated with a higher risk of breast cancer among postmenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/9-14\">",
"     9-14",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a 2000 analysis of seven cohort studies, women with a BMI &gt;33",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      had a higher breast cancer risk compared with those with a BMI &lt;21",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      (relative risk [RR] 1.27, 95% CI 1.03-1.55)",
"      <sup>",
"      </sup>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the Nurses' Health Study, women who gained 10 kg or more since menopause had a higher risk of breast cancer compared with women who maintained their weight (400 versus 339 per 100,000 person-years; RR 1.18, 95% VI 1.03-1.35) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The association between a higher BMI and postmenopausal breast cancer risk may be explained by higher estrogen levels resulting from the peripheral conversion of estrogen precursors (from adipose tissue) to estrogen [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/15\">",
"     15",
"    </a>",
"    ]. In addition, hyperinsulinemia may also explain the obesity-breast cancer relationship because a high BMI is associated with higher insulin levels [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Estrogen exposure'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H9305674\">",
"     'Insulin pathway and related hormones'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9303044\">",
"    <span class=\"h3\">",
"     Premenopausal women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unlike postmenopausal women, an increased BMI is associated with a",
"    <strong>",
"     lower",
"    </strong>",
"    risk of breast cancer in premenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/9,17\">",
"     9,17",
"    </a>",
"    ]. In the 2000 pooled analysis discussed above, premenopausal women with a BMI &ge;31",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    were 46 percent less likely to develop breast cancer than those with a BMI &lt;21",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/9\">",
"     9",
"    </a>",
"    ]. The explanation of this finding remains unclear.",
"    <br/>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9303051\">",
"    <span class=\"h2\">",
"     Tall stature",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased height is associated with a higher risk of breast cancer in both premenopausal and postmenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/9,10,18,19\">",
"     9,10,18,19",
"    </a>",
"    ]. In one study, women who were &gt;175 cm (69 inches) tall were 20 percent more likely to develop breast cancer than those &lt;160 cm (63 inches) tall [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/9\">",
"     9",
"    </a>",
"    ]. The mechanism underlying this association is not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Estrogen exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;High endogenous estrogen levels increase the risk of breast cancer (particularly hormone receptor-positive breast cancer) in both postmenopausal and premenopausal women.",
"   </p>",
"   <p>",
"    For postmenopausal women, the correlation between an increased risk for breast cancer and increasing hormone levels (eg, estradiol, estrone) has been fairly consistent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/20-25\">",
"     20-25",
"    </a>",
"    ]. Further support of a role for estrogen and an increased risk of breast cancer come from the finding that reducing estrogen levels (eg, with the administration of aromatase inhibitors) reduces the risk of breast cancer. (See",
"    <a class=\"local\" href=\"#H9303037\">",
"     'Postmenopausal women'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The limited data suggest that estrogen levels also play a role in the development of breast cancer among premenopausal women. In a study nested within the Nurses&rsquo; Health study that included 591 premenopausal women (197 subsequently diagnosed with breast cancer), women in the highest quartile for serum estrogen levels had an increased breast cancer risk compared with those in the lowest quartile (RR 2.4, 95% CI 1.3-4.5) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33002095\">",
"    <span class=\"h3\">",
"     Benign breast disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;A wide spectrum of pathologic entities is included in the category of benign breast disease. Among these, proliferative lesions (especially those with histologic atypia) are associated with an increased risk of breast cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11081?source=see_link\">",
"     \"Overview of benign breast disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2354325194\">",
"    <span class=\"h3\">",
"     Dense breast tissue",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of breast cancer is four to five times greater in women with mammographically dense breasts (usually defined as &ge;75 percent density) compared with women of similar age with less or no dense tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/27-30\">",
"     27-30",
"    </a>",
"    ]. In addition, longitudinal increases or decreases in breast density on serial screening mammography are associated with an increased or decreased risk of breast cancer, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/31\">",
"     31",
"    </a>",
"    ]. However, increased breast density is not associated with mortality from breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/49/41754?source=see_link\">",
"     \"Screening for breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Breast density does not appear to a specific breast cancer subtype [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. In one study involving 44,811 participants in the San Francisco Mammography Registry, breast cancers arising in the context of dense breast tissue were as likely to be estrogen receptor (ER) positive (hazard ratio [HR] 2.21, 95% CI 1.64-3.04) as they were to be ER negative (HR 2.21, 95% CI 1.16-4.18) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although breast density is a largely inherited trait, exogenous hormones can influence density [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/35-38\">",
"     35-38",
"    </a>",
"    ]. For example, menopausal hormone therapy increases breast density, while estrogen receptor antagonists (ie,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    ) decrease breast density. Despite this association, breast density is not strongly correlated with endogenous hormone levels [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067591809\">",
"    <span class=\"h3\">",
"     Bone mineral density",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because bone contains estrogen receptors and is highly sensitive to circulating estrogen levels, bone mineral density (BMD) is considered a surrogate marker for long-term exposure to endogenous estrogen. In multiple studies, women with higher bone density have a higher breast cancer risk [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/40-43\">",
"     40-43",
"    </a>",
"    ]. In a 2008 study from the Women&rsquo;s Health Initiative (n = 9941 postmenopausal women), each unit increase in the total hip BMD T-score was associated with an increased risk of breast cancer (HR 1.25, 95% CI 1.11-1.40). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/55/11128?source=see_link&amp;anchor=H8#H8\">",
"     \"Diagnosis and evaluation of osteoporosis in postmenopausal women\", section on 'T-score'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067591882\">",
"    <span class=\"h2\">",
"     Other hormonal factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2354326433\">",
"    <span class=\"h3\">",
"     Androgens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preclinical data suggest that androgens (in particular, testosterone) exert dual effects on breast tumorigenesis, with a proliferative effect mediated by the ER, and an antiproliferative effect mediated by the androgen receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/44\">",
"     44",
"    </a>",
"    ]. Elevated androgen (ie, testosterone) levels have been associated with an increased risk of postmenopausal and premenopausal breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/22,26,45-47\">",
"     22,26,45-47",
"    </a>",
"    ], although this has not been consistently demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Other studies suggest that elevated androgen levels increase the risk specifically for hormone receptor-positive breast cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/26,45-47\">",
"     26,45-47",
"    </a>",
"    ], and one study suggests they are associated with a lower risk of hormone receptor-negative breast cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9305674\">",
"    <span class=\"h3\">",
"     Insulin pathway and related hormones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although diabetes is not considered a breast cancer risk factor [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/50\">",
"     50",
"    </a>",
"    ], a large pooled analysis drawing from 17 prospective studies suggested that insulin growth factor-1 was associated with breast cancer risk in both premenopausal and postmenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <br/>",
"    In addition, the Women&rsquo;s Health Initiative reported that higher endogenous insulin levels were associated with an increased risk of breast cancer among nondiabetic, postmenopausal women who did not take menopausal hormone therapy (HR for highest versus lowest quartile of insulin level 2.40, 95% CI 1.30-4.41) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H439557597\">",
"    <span class=\"h3\">",
"     In utero exposure to diethylstilbestrol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before 1971, several million women were exposed in utero to diethylstilbestrol (DES) that was given to their mothers to prevent pregnancy complications. Whether these women are also at an increased risk for breast cancer is unclear:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A long-term follow-up study of 4653 DES-exposed women and 1927 unexposed controls reported a nearly twofold increase in the cumulative risk of breast cancer in exposed women aged 40 or older (3.9 versus 2.2 percent, HR 1.82, 95% CI 1.04-3.08) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      On the other hand, in a long-term follow-up study of 12,091 DES exposed women in the Netherlands, there was no excess risk for breast cancer when compared with Dutch population-based controls, even when the analysis was restricted to women over the age of 40 (standardized incidence ratio [SIR] 1.09, 95% CI 0.91-1.31) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The follow-up of women exposed to DES in utero is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3322?source=see_link&amp;anchor=H3#H3\">",
"     \"Outcome and follow-up of diethylstilbestrol (DES) exposed individuals\", section on 'Women exposed to DES in-utero (DES daughters)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2354326496\">",
"    <span class=\"h3\">",
"     Exogenous hormones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Much of the available evidence supports a causal relationship between menopausal hormone therapy and breast cancer. The duration of use and type of hormone formulation seem to be important factors in the risk for breast cancer (",
"    <a class=\"graphic graphic_table graphicRef64508 \" href=\"UTD.htm?15/52/16205\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    While long-term use has been associated with the highest risk, short-term use of combined estrogen-progestin therapy (less than three years in previous users of estrogen) does not appear to significantly increase the risk of breast cancer.",
"   </p>",
"   <p>",
"    However, the administration of exogenous hormones as oral contraceptives or for the purpose of ovulation induction is not clearly associated with an increased risk of breast cancer.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/11/11449?source=see_link\">",
"       \"Postmenopausal hormone therapy and the risk of breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link&amp;anchor=H22#H22\">",
"       \"Risks and side effects associated with estrogen-progestin contraceptives\", section on 'Breast cancer'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link&amp;anchor=H26#H26\">",
"       \"Overview of ovulation induction\", section on 'Breast cancer'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067591470\">",
"    <span class=\"h2\">",
"     Reproductive factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H455514459\">",
"    <span class=\"h3\">",
"     Earlier menarche or later menopause",
"    </span>",
"    &nbsp;&mdash;&nbsp;Younger age at menarche is associated with a higher risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. In one study, for every two-year delay in the onset of menarche, there was a 10 percent reduction in cancer risk [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/54\">",
"     54",
"    </a>",
"    ]. In addition, later age at menopause increases breast cancer risk [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/55-57\">",
"     55-57",
"    </a>",
"    ]. The relative risk increases by 1.03 percent for each year older at menopause, which is comparable to the increase with the use of menopausal hormone therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067591498\">",
"    <span class=\"h3\">",
"     Nulliparity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nulliparous women are at increased risk for breast cancer compared with parous women (RR from 1.2 to 1.7) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/55,56,58\">",
"     55,56,58",
"    </a>",
"    ]. However, the protective effect of pregnancy is not seen until after 10 years following delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/59\">",
"     59",
"    </a>",
"    ]. Whether multiparity confers protection against breast cancer is controversial, although studies suggest a decreased risk with increasing number of pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/55,56,58,59\">",
"     55,56,58,59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H455514540\">",
"    <span class=\"h4\">",
"     Infertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association between infertility and breast cancer risk is controversial. Several epidemiologic studies suggest that infertility due to anovulatory disorders decreases the risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. However, other studies have observed either no association or a slight increase in risk associated with infertility after adjusting for prior pregnancy history and age at first delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/63,64\">",
"     63,64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067591505\">",
"    <span class=\"h3\">",
"     Increasing age at first pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who become pregnant later in life have an increased risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/55,56,58\">",
"     55,56,58",
"    </a>",
"    ]. In the Nurses' Health Study, when compared to nulliparous women at or near menopause, the cumulative incidence of breast cancer (up to age 70) was 20 percent lower, 10 percent lower, and 5 percent lower among women who delivered their first child at age 20, 25, or 35 years, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/55\">",
"     55",
"    </a>",
"    ]. The risk for a nulliparous woman was similar to that of a woman with a first full term birth at age 35.",
"   </p>",
"   <p>",
"    It has been proposed that full cellular differentiation, which occurs in the gland during and after pregnancy, protects the breast from breast cancer development [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/65\">",
"     65",
"    </a>",
"    ]. A later age at first birth may confer a greater risk than nulliparity because of the additional proliferative stimulation placed on breast cells that are more likely to be fully developed and perhaps more prone to cell damage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067591512\">",
"    <span class=\"h3\">",
"     Absence of breastfeeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;A protective effect of breastfeeding has been shown in multiple case-control and cohort studies, the magnitude of which depends on the duration of breastfeeding and on the confounding factor of parity [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/66-70\">",
"     66-70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A large pooled analysis that included individual data from 47 epidemiologic studies (50,302 women with invasive breast cancer and 96,973 controls) estimated that for every 12 months of breastfeeding, there was a 4.3 percent reduction in the relative risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/69\">",
"     69",
"    </a>",
"    ]. A postulated mechanism for the protective effect of breastfeeding is that it may delay the reestablishment of ovulatory cycles.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067592185\">",
"    <span class=\"h2\">",
"     Personal history of breast cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;A personal history of ductal carcinoma in situ (DCIS) or invasive breast cancer increases the risk of developing an invasive breast cancer in the contralateral breast. A 2010 study using Surveillance, Epidemiology, and End-Results (SEER) data that included almost 340,000 women with a primary breast cancer found the incidence of invasive contralateral breast cancer was 4 percent during an average follow-up of 7.5 years [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/71\">",
"     71",
"    </a>",
"    ]. The risk of a contralateral breast cancer varied by age at the time of the index breast cancer diagnosis and the hormone receptor status of the primary cancer:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For women with a prior ER-positive breast cancer &mdash; The rate (per 100 woman years) was slightly higher for women diagnosed under 30 years compared with those diagnosed at an older age (0.45 versus 0.25 to 0.37, respectively). Notably, these rates have been decreasing over time, most likely due to the wider use of hormonal therapy.",
"     </li>",
"     <li>",
"      For women with a prior ER-negative breast cancer &mdash; The rate was highest among women &lt;30 years at diagnosis compared with those diagnosed at an older age (1.26 versus 0.85 at age 30 to 35 years, and 0.45 to 0.64 for diagnoses &ge;40 years).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These rates were not altered with inclusion of in situ carcinomas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067592212\">",
"    <span class=\"h2\">",
"     Family history of breast cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk associated with a positive family history of breast cancer is strongly affected by the number of female first-degree relatives with and without cancer. As an example, in a pooled analysis using data from over 50,000 women with breast cancer and 100,000 controls, the risk of breast cancer was [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/72\">",
"     72",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased almost twofold if a woman had one affected first-degree relative",
"     </li>",
"     <li>",
"      Increased threefold if she had two affected first-degree relatives",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to a family history of breast cancer, the age at diagnosis of the affected first-degree relative also influences the risk for breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/72\">",
"     72",
"    </a>",
"    ]. Women have a threefold higher risk if the first degree relative was diagnosed before age 30 (RR 3.0, 95% CI 1.8-4.9), but only 1.5-fold increased if the affected relative was diagnosed after age 60. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/51/2872?source=see_link&amp;anchor=H10#H10\">",
"     \"Risk prediction models for breast cancer screening\", section on 'Models emphasizing family risk'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067592239\">",
"    <span class=\"h2\">",
"     Inherited genetic mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific genetic mutations that predispose to breast cancer are rare; only 5 to 6 percent of all breast cancers are directly attributable to inheritance of a breast cancer susceptibility gene such as BRCA1, BRCA2, p53, ATM, and PTEN (",
"    <a class=\"graphic graphic_table graphicRef66808 \" href=\"UTD.htm?11/38/11884\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=see_link\">",
"     \"Characteristics of hereditary breast and ovarian cancer syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446695404\">",
"    <span class=\"h1\">",
"     LIFESTYLE FACTORS",
"    </span>",
"   </p>",
"   <p>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446695412\">",
"    <span class=\"h2\">",
"     Physical inactivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;While there is no direct evidence that inactivity is associated with an increased risk of breast cancer, regular physical exercise appears to provide modest protection against breast cancer, particularly in postmenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/73-77\">",
"     73-77",
"    </a>",
"    ]. A 2011 review of epidemiologic studies estimated that risk of breast cancer was reduced by 25 percent among physically active women compared with women who were the least active [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the paradoxical effect of weight in premenopausal and postmenopausal women, the reduction in breast cancer risk seen with exercise is likely not mediated through weight control alone [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/74,78-80\">",
"     74,78-80",
"    </a>",
"    ]. Increased physical activity may reduce breast cancer risk through hormonal influences, such as reducing serum estrogens, insulin, and insulin growth factor-1 levels [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/81-83\">",
"     81-83",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9303004\">",
"     'Weight'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H9\">",
"     'Estrogen exposure'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H9305674\">",
"     'Insulin pathway and related hormones'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H106517866\">",
"    <span class=\"h2\">",
"     Alcohol",
"    </span>",
"    &nbsp;&mdash;&nbsp;There appears to be a significant dose-response relationship between alcohol consumption and an increased risk of breast cancer, which begins with alcohol intake as low as three drinks per week. The risk appears to increase with greater alcohol consumption and additive with the use of menopausal hormone therapy. There does not appear to be a difference by type of alcohol (wine versus beer versus liquor). This topic is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/61/38874?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of the risks and benefits of alcohol consumption\", section on 'Breast cancer'",
"    </a>",
"    .)",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446695419\">",
"    <span class=\"h2\">",
"     Smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between cigarette smoking and breast cancer has been complicated by the interaction of smoking with alcohol and endogenous hormonal influences [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/84-87\">",
"     84-87",
"    </a>",
"    ]. Although results have varied widely, multiple studies suggest there is a modestly increased risk of breast cancer in smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/87-90\">",
"     87-90",
"    </a>",
"    ], although others have not [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/85,91\">",
"     85,91",
"    </a>",
"    ]. Increased risks are most consistent in studies that evaluated early initiation, longer duration,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    higher pack-years of smoking. In addition, one study suggests that the risk of breast cancer may be particularly important in N-acetyltransferase 2 (NAT2) slow acetylators with a long pack-year smoking history (&ge;20) (relative risk [RR] 1.44, 95 percent CI 1.23-1.68 compared to never smokers) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The association between breast cancer risk and exposure to passive smoking is inconclusive.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a 2011 report from the Women&rsquo;s Health Initiative Observational study of almost 80,000 women, nonsmokers who reported extensive exposure to cigarette smoke (defined as &ge;10 years&rsquo; exposure in childhood, &ge;20 years&rsquo; as an adult at home, or &ge;10 years&rsquo; occupational exposure) had a higher risk of breast cancer compared to those who were not exposed to cigarette smoke (hazard ratio [HR] 1.32, 95% CI 1.04-1.67) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/93\">",
"       93",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      However, a report from the Nurses&rsquo; Health Study found no association between passive smoking and breast cancer risk among a cohort of over 1800 women (920 with a diagnosis of breast cancer) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/94\">",
"       94",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446696258\">",
"    <span class=\"h1\">",
"     DIETARY FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The influence of diet on breast cancer risk is not clear. Methodologic issues regarding the measurement of nutritional intake and the contribution of other factors (eg, alcohol use) complicate these analyses and the interpretation of studies. A summary of what is known about dietary intake and breast cancer risk is discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446696265\">",
"    <span class=\"h2\">",
"     Dietary pattern",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of dietary patterns on breast cancer risk is not clear. A 2010 meta-analysis of studies evaluating breast cancer risk reported that high consumption of a diet composed predominantly of fruits and vegetables resulted in a lower risk of breast cancer (odds ratio [OR] 0.89, 95% CI 0.82-0.99) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/95\">",
"     95",
"    </a>",
"    ]. There was no influence on the risk of breast cancer among women who reported a high intake of",
"    <span class=\"nowrap\">",
"     red/processed",
"    </span>",
"    meats, refined grains, sweets, and high-fat dairy (OR 1.09, 95% CI 0.98-1.22). &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446696272\">",
"    <span class=\"h2\">",
"     Fat intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;While there is an association between fat intake and breast cancer risk, it does not appear to be a strong one. However, there may be a modest difference when comparing extremes of fat intake.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 2003 meta-analysis reported a small but significant impact of high fat diets on breast cancer risk among humans [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/96\">",
"       96",
"      </a>",
"      ]. Compared to the lowest levels of total fat intake, the highest levels of fat intake were associated with a trend towards an increased risk of breast cancer (summary RR 1.13, 95% CI 0.99-1.32).",
"     </li>",
"     <li>",
"      In the dietary modification arm of the Women's Health Initiative, 48,835 healthy postmenopausal women aged 50 to 79 were randomly assigned to an intervention (monthly group sessions in the first year followed by quarterly maintenance sessions with the goal of reducing fat intake) or a comparison group that received nutrition information alone [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/60\">",
"       60",
"      </a>",
"      ]. At a mean follow-up of 8.1 years, there was no effect on breast cancer risk seen in the intervention group (HR 0.91, CI 0.83-1.01). However, few women met the target of 20 percent of energy from fat. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2601?source=see_link&amp;anchor=H5#H5\">",
"       \"Dietary fat\", section on 'Cancer'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In the AARP Diet and Health Study, women in the highest quintile of fat intake (median 90",
"      <span class=\"nowrap\">",
"       g/day,",
"      </span>",
"      40 percent of total calories from fat) had rates of invasive breast cancer 11 to 22 percent higher than those of women in the lowest quintile (median 24.2",
"      <span class=\"nowrap\">",
"       g/day,",
"      </span>",
"      or 20 percent of calories from fat) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/97\">",
"       97",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446696279\">",
"    <span class=\"h2\">",
"     Red meat and processed meat",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association between intake of red meat (&gt;5 servings per week) and premenopausal breast cancer has been reported in a few studies, but the evidence linking this to breast cancer risk is weaker than that for other cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/96,98,99\">",
"     96,98,99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9304760\">",
"    <span class=\"h2\">",
"     Soy/Phytoestrogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phytoestrogens are naturally occurring plant substances with a chemical structure similar to 17-beta estradiol. They consist mainly of isoflavones (found in high concentrations in soy beans and other legumes) and lignans (found in a variety of fruits, vegetables, and cereal products). There is low quality evidence that soy-rich diets in Western women prevent breast cancer.",
"   </p>",
"   <p>",
"    A 2008 meta-analysis of eight studies evaluating the impact of soy food intake and breast cancer risk reported the following results [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/100\">",
"     100",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among Asian women, a higher intake of isoflavones (&ge;20 mg per day) was associated with a 29 percent reduction in breast cancer risk with evidence of a dose-response relationship.",
"     </li>",
"     <li>",
"      Among Western women, there was no association with soy intake. However, the highest level of soy intake was only about 0.8 mg daily, which may not have been sufficient to observe an effect.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9304767\">",
"    <span class=\"h2\">",
"     Caffeine",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have failed to show any association between caffeine intake and breast cancer risk [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/101,102\">",
"     101,102",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/5/17498?source=see_link\">",
"     \"Benefits and risks of caffeine and caffeinated beverages\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446696286\">",
"    <span class=\"h1\">",
"     ENVIRONMENTAL FACTORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446696293\">",
"    <span class=\"h2\">",
"     Geographic residence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within the United States, geographic cluster regions with high breast cancer incidence rates have been identified, such as Cape Cod, Massachusetts; Long Island, New York; and Marin County, California [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/103-105\">",
"     103-105",
"    </a>",
"    ]. These clusters are most likely due to regional differences in established breast cancer risk factors, but studies are ongoing to better understand these clusters [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446696300\">",
"    <span class=\"h2\">",
"     Exposure to ionizing radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exposure to ionizing radiation of the chest at a young age, as occurs with treatment of Hodgkin lymphoma or in survivors of atomic bomb or nuclear plant accidents, is associated with an increased risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/107-111\">",
"     107-111",
"    </a>",
"    ]. The most vulnerable ages appear to be between 10 to 14 years (prepuberty), although excess risk is seen in women exposed as late as 45 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/112\">",
"     112",
"    </a>",
"    ]. After age 45, there does not appear to be any increased risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/26/35242?source=see_link\">",
"     \"Second malignancies after treatment of classical Hodgkin lymphoma\"",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    Whether there is a link between breast cancer risk and diagnostic levels of irradiation (eg, mammography, chest radiographs, diagnostic spine imaging, computed tomography [CT] scans) in women without an inherited predisposition is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/113,114\">",
"     113,114",
"    </a>",
"    ]. However, the risk of breast cancer associated with diagnostic radiation in women with an inherited",
"    <span class=\"nowrap\">",
"     BRCA1/2",
"    </span>",
"    mutation appears to be increased [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/115-117\">",
"     115-117",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/49/41754?source=see_link&amp;anchor=H32#H32\">",
"     \"Screening for breast cancer\", section on 'Radiation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446696314\">",
"    <span class=\"h2\">",
"     Night shift work",
"    </span>",
"    &nbsp;&mdash;&nbsp;Night shift work is recognized by International Agency for Research on Cancer and the World Health Organization",
"    <span class=\"nowrap\">",
"     (IARC/WHO)",
"    </span>",
"    as a probable carcinogen [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/118\">",
"     118",
"    </a>",
"    ]. This is supported by the following studies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/119-121\">",
"     119-121",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 2005 meta-analysis exploring the relationship between night work and breast cancer risk included 13 studies of airline cabin attendants and nighttime shift workers and reported a relative risk of 1.48 (95% CI 1.36-1.61) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/120\">",
"       120",
"      </a>",
"      ]. The risk was similar between both female air cabin crew (relative risk [RR] 1.51, 95% CI 1.36-1.68) and female night workers (RR 1.44, 95% CI 1.26-1.65).",
"     </li>",
"     <li>",
"      A 2012 study on nurses reported that working shifts after midnight was associated with an elevated risk of breast cancer (odds ratio [OR] 1.8, 95% CI 1.2-2.8), with the highest risk noted in nurses working long-term day to night rotating shifts (OR 2.6, 95% CI 1.8-3.8) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/121\">",
"       121",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This association may be related to nocturnal light exposure, which results in the suppression of nocturnal melatonin production by the pineal gland [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/122\">",
"     122",
"    </a>",
"    ]. Evidence to support this comes from the finding that low levels of 6-sulfatoxymelatonin (the major melatonin metabolite) are associated with an increased risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/122,123\">",
"     122,123",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13034?source=see_link\">",
"     \"Physiology and clinical use of melatonin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9305001\">",
"    <span class=\"h1\">",
"     MEDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several medication classes may have a modifying effect on breast cancer risk. However, the evidence to support their association to breast cancer is weak. These include the following:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9305250\">",
"    <span class=\"h2\">",
"     Calcium/Vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no consistently reported association between the intake of vitamin D with or without calcium and the risk of breast cancer, though a lowered risk has been reported among premenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/124-128\">",
"     124-128",
"    </a>",
"    ]. A 2011 meta-analysis of the United States Preventive Services Task Force that included three trials (n = 40,147) found no dose-response relationship between vitamin D plus calcium intake and the risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/129\">",
"     129",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The",
"    <a class=\"external\" href=\"file://clinicaltrials.gov/ct2/show/NCT01169259\">",
"     VITAL trial",
"    </a>",
"    will be investigating the role of higher dose vitamin D supplementation (2000 international units) with or without omega 3 supplements on a variety of outcomes, including the risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/130\">",
"     130",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9305257\">",
"    <span class=\"h2\">",
"     Antioxidants",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence for an effect of intake of vitamin A, E, or C or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    on breast cancer risk [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/131,132\">",
"     131,132",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9305267\">",
"    <span class=\"h2\">",
"     Nonsteroidal anti-inflammatory drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The data regarding a possible protective effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on breast cancer risk are mixed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of 38 studies concluded that any NSAID use was associated with a reduction in breast cancer risk (relative risk [RR] 0.88, 95% CI 0.84-0.93), with similar reductions for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      (RR 0.87, 95% CI 0.82-0.92) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"       ibuprofen",
"      </a>",
"      (RR 0.79, 95% CI 0.64-0.97) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/133\">",
"       133",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      However, a 2012 report from the Nurses&rsquo; Health Study found no association between the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      , NSAIDs, or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      and the incidence of breast cancer (overall or by hormone receptor status) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/134\">",
"       134",
"      </a>",
"      ]. In addition, the only randomized trial reported that evaluated the impact of low-dose aspirin (100 mg every other day) on cancer prevention found no effect on breast cancer or total cancer after an average of 10 years of follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/135\">",
"       135",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9305274\">",
"    <span class=\"h2\">",
"     Bisphosphonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral bisphosphonates are commonly used for the treatment of osteoporosis and for women with breast cancer with evidence of bone loss attributed to aromatase inhibitors. Whether their use is a true protective factor is unclear. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40842?source=see_link\">",
"     \"Bisphosphonates in the management of osteoporosis in postmenopausal women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/35/33336?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of the use of osteoclast inhibitors in early breast cancer\", section on 'Prevention of treatment-related bone loss'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several studies suggest a protective effect of oral bisphosphonates, with a 28 to 33 percent reduction in the risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/136-139\">",
"     136-139",
"    </a>",
"    ]. However, low bone density is associated with a decreased risk of breast cancer. (See",
"    <a class=\"local\" href=\"#H1067591809\">",
"     'Bone mineral density'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Therefore, it is not known if the studies are observing a true causal association between bisphosphonates and breast cancer risk reduction or simply confounding by indication (ie, people who take bisphosphonates are at lower breast cancer risk to begin with).",
"   </p>",
"   <p>",
"    The potentially protective effect of bisphosphonates in the adjuvant setting of women diagnosed with breast cancer is an ongoing area of research. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/35/33336?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of the use of osteoclast inhibitors in early breast cancer\", section on 'Prevention of breast cancer recurrence'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9304529\">",
"    <span class=\"h1\">",
"     FACTORS THAT DO NOT INFLUENCE BREAST CANCER RISK",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9304554\">",
"    <span class=\"h2\">",
"     Abortion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both a large pooled analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/140\">",
"     140",
"    </a>",
"    ] and population-based cohort studies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/141-145\">",
"     141-145",
"    </a>",
"    ] do not support an association between abortion (induced or spontaneous) and breast cancer risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H106517721\">",
"    <span class=\"h2\">",
"     Chemicals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Organochlorines include polychlorinated biphenyls (PCB's), dioxins, and organochlorine pesticides such as dichlorodiphenyltrichloroethane (DDT). These compounds are weak estrogens, highly lipophilic, and capable of persisting in body tissues for years. However, an association with breast cancer has not been demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/146,147\">",
"     146,147",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86339679\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cosmetic breast implants, electromagnetic fields, electric blankets, and hair dyes have not been associated with breast cancer risk [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/147,148\">",
"     147,148",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9303838\">",
"    <span class=\"h1\">",
"     QUANTIFYING RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/51/2872?source=see_link\">",
"     \"Risk prediction models for breast cancer screening\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446697232\">",
"    <span class=\"h1\">",
"     REDUCING BREAST CANCER RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although screening mammography does not reduce the risk of developing breast cancer, screening significantly decreases the risk of dying from breast cancer. These approaches and other recommendations to reduce breast cancer risk are covered separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/49/41754?source=see_link\">",
"     \"Screening for breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For women at an increased risk of developing breast cancer, chemoprevention should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44246?source=see_link\">",
"     \"Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For all women, the following approaches may reduce the risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/149\">",
"     149",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Planning for first birth before the age of 30 (see",
"      <a class=\"local\" href=\"#H1067591505\">",
"       'Increasing age at first pregnancy'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Breastfeeding for at least six months (see",
"      <a class=\"local\" href=\"#H1067591512\">",
"       'Absence of breastfeeding'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Avoidance or limited duration of use of postmenopausal hormone therapy (see",
"      <a class=\"local\" href=\"#H2354326496\">",
"       'Exogenous hormones'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=see_link\">",
"       \"Postmenopausal hormone therapy: Benefits and risks\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Avoidance of unnecessary exposure to radiation (eg, inappropriate use of computed tomography) (see",
"      <a class=\"local\" href=\"#H2446696300\">",
"       'Exposure to ionizing radiation'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Avoidance or cessation of smoking (see",
"      <a class=\"local\" href=\"#H2446695419\">",
"       'Smoking'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Limiting alcohol intake (see",
"      <a class=\"local\" href=\"#H106517866\">",
"       'Alcohol'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/24/42378?source=see_link&amp;anchor=H27#H27\">",
"       \"Cancer prevention\", section on 'Alcohol'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Maintenance of a healthy weight (see",
"      <a class=\"local\" href=\"#H9303004\">",
"       'Weight'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Limiting nocturnal shift work (see",
"      <a class=\"local\" href=\"#H2446696314\">",
"       'Night shift work'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Adopting a physically active lifestyle. This should include at least 150 minutes of weekly moderate intensity activity, 75 minutes of weekly vigorous intensity activity, or at least some physical activity above one&rsquo;s usual routine, in addition to limiting sedentary behavior [",
"      <a class=\"abstract\" href=\"UTD.htm?28/17/28954/abstract/150\">",
"       150",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (See",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/6/44134?source=see_link\">",
"       \"Patient information: Factors that modify breast cancer risk in women (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2446697319\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increasing age, female gender, and white race are all established risk factors for a diagnosis of breast cancer. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Increasing age'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2354324740\">",
"       'Female gender'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'White race'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For postmenopausal women, obesity is associated with an increased risk of breast cancer, particularly in women who do not use hormone therapy. However, a higher body mass index has been associated with a lower risk of breast cancer in premenopausal women. (See",
"      <a class=\"local\" href=\"#H9303004\">",
"       'Weight'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Increased exposure to estrogen is a risk factor for developing breast cancer. Risk factors that reflect increased estrogen exposure include: earlier menarche or later menopause, a history of proliferative breast lesions with atypia, dense breast tissue, and a high bone mineral density. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Estrogen exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reproductive factors that increase breast cancer risk include: later age at the time of first pregnancy, absence of breastfeeding, and nulliparity. However, infertility and prior abortions do not alter the risk of breast cancer. (See",
"      <a class=\"local\" href=\"#H1067591470\">",
"       'Reproductive factors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9304554\">",
"       'Abortion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Regular physical exercise appears to provide modest protection against breast cancer, on the order of 15 to 30 percent. (See",
"      <a class=\"local\" href=\"#H2446695412\">",
"       'Physical inactivity'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2446697232\">",
"       'Reducing breast cancer risk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Alcohol consumption has been associated with an increased risk of breast cancer with a dose-response relationship. (See",
"      <a class=\"local\" href=\"#H106517866\">",
"       'Alcohol'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Active smoking may be a weak risk factor, but whether passive exposure to cigarette smoke is a risk factor is not clear. (See",
"      <a class=\"local\" href=\"#H2446695419\">",
"       'Smoking'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A diet rich in fruit, vegetables, poultry, fish, low-fat dairy, and whole grains is possibly associated with a reduced risk of breast cancer, but is clearly beneficial for overall health. There is little evidence that eating soy or drinking caffeine as part of a Western diet influences breast cancer risk. (See",
"      <a class=\"local\" href=\"#H2446696258\">",
"       'Dietary factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Environmental factors associated with an increased risk of breast cancer include: exposure to ionizing radiation in",
"      <span class=\"nowrap\">",
"       childhood/early",
"      </span>",
"      adult life and longer duration of night shift work. (See",
"      <a class=\"local\" href=\"#H2446696286\">",
"       'Environmental factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although screening mammography does not reduce the risk of developing breast cancer, screening significantly decreases the risk of dying from breast cancer. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/49/41754?source=see_link\">",
"       \"Screening for breast cancer\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H2446697232\">",
"       'Reducing breast cancer risk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women at high-risk of developing breast cancer, chemoprevention should be considered. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44246?source=see_link\">",
"       \"Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Table 1.10. Age Distribution (%) of Incidence Cases by Site, 2004-2008, All Races, Both Sexes. file://seer.cancer.gov/csr/1975_2008/results_single/sect_01_table.10_2pgs.pdf (Accessed on April 06, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/2\">",
"      Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/3\">",
"      Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011; 103:714.",
"     </a>",
"    </li>",
"    <li>",
"     American Cancer Society. Breast Cancer Facts &amp; Figures 2009-2010, American Cancer Society, Inc, Atlanta.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/5\">",
"      CDC. Vital Signs: Racial Disparities in Breast Cancer Severity &mdash; United States, 2005-2009. MMWR Morb Mortal Wkly Rep 2012; 61:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/6\">",
"      Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002; 94:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/7\">",
"      Palmer JR, Wise LA, Horton NJ, et al. Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst 2003; 95:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/8\">",
"      Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295:2492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/9\">",
"      van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/10\">",
"      Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004; 111:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/11\">",
"      Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA 2006; 296:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/12\">",
"      Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002; 13:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/13\">",
"      Feigelson HS, Jonas CR, Teras LR, et al. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2004; 13:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/14\">",
"      Ahn J, Schatzkin A, Lacey JV Jr, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 2007; 167:2091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/15\">",
"      Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/16\">",
"      Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009; 101:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/17\">",
"      Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 2012; 156:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/18\">",
"      Ahlgren M, Melbye M, Wohlfahrt J, S&oslash;rensen TI. Growth patterns and the risk of breast cancer in women. N Engl J Med 2004; 351:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/19\">",
"      Green J, Cairns BJ, Casabonne D, et al. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 2011; 12:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/20\">",
"      Key T, Appleby P, Barnes I, et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/21\">",
"      Lippman ME, Krueger KA, Eckert S, et al. Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. J Clin Oncol 2001; 19:3111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/22\">",
"      Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004; 96:1856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/23\">",
"      Beattie MS, Costantino JP, Cummings SR, et al. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). J Natl Cancer Inst 2006; 98:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/24\">",
"      Farhat GN, Cummings SR, Chlebowski RT, et al. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst 2011; 103:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/25\">",
"      Sieri S, Krogh V, Bolelli G, et al. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2009; 18:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/26\">",
"      Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006; 98:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/27\">",
"      Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/28\">",
"      Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005; 6:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/29\">",
"      McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/30\">",
"      Wong CS, Lim GH, Gao F, et al. Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer 2011; 104:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/31\">",
"      Kerlikowske K, Ichikawa L, Miglioretti DL, et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 2007; 99:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/32\">",
"      Gierach GL, Ichikawa L, Kerlikowske K, et al. Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst 2012; 104:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/33\">",
"      Ziv E, Tice J, Smith-Bindman R, et al. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13:2090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/34\">",
"      Yaghjyan L, Colditz GA, Collins LC, et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 2011; 103:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/35\">",
"      Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002; 347:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/36\">",
"      Vachon CM, Sellers TA, Carlson EE, et al. Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 2007; 67:8412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/37\">",
"      Irwin ML, Aiello EJ, McTiernan A, et al. Physical activity, body mass index, and mammographic density in postmenopausal breast cancer survivors. J Clin Oncol 2007; 25:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/38\">",
"      Boyd NF, Greenberg C, Lockwood G, et al. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J Natl Cancer Inst 1997; 89:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/39\">",
"      Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2007; 99:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/40\">",
"      Zmuda JM, Cauley JA, Ljung BM, et al. Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst 2001; 93:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/41\">",
"      Zhang Y, Kiel DP, Kreger BE, et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 1997; 336:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/42\">",
"      Cauley JA, Lucas FL, Kuller LH, et al. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 1996; 276:1404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/43\">",
"      Chen Z, Arendell L, Aickin M, et al. Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative. Cancer 2008; 113:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/44\">",
"      Brettes JP, Mathelin C. [Dual effects of androgens on mammary gland]. Bull Cancer 2008; 95:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/45\">",
"      Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005; 97:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/46\">",
"      Dorgan JF, Stanczyk FZ, Kahle LL, Brinton LA. Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk. Breast Cancer Res 2010; 12:R98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/47\">",
"      Tworoger SS, Missmer SA, Eliassen AH, et al. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/48\">",
"      Wysowski DK, Comstock GW, Helsing KJ, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987; 125:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/49\">",
"      Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 1997; 75:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/50\">",
"      Wolf I, Sadetzki S, Catane R, et al. Diabetes mellitus and breast cancer. Lancet Oncol 2005; 6:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/51\">",
"      Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, et al. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/52\">",
"      Hoover RN, Hyer M, Pfeiffer RM, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 2011; 365:1304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/53\">",
"      Verloop J, van Leeuwen FE, Helmerhorst TJ, et al. Cancer risk in DES daughters. Cancer Causes Control 2010; 21:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/54\">",
"      Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasa S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer 1990; 46:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/55\">",
"      Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 2000; 152:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/56\">",
"      Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/57\">",
"      Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997; 350:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/58\">",
"      Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol 1994; 139:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/59\">",
"      Bruzzi P, Negri E, La Vecchia C, et al. Short term increase in risk of breast cancer after full term pregnancy. BMJ 1988; 297:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/60\">",
"      Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/61\">",
"      Gammon MD, Thompson WD. Infertility and breast cancer: a population-based case-control study. Am J Epidemiol 1990; 132:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/62\">",
"      Rossing MA, Daling JR, Weiss NS, et al. Risk of breast cancer in a cohort of infertile women. Gynecol Oncol 1996; 60:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/63\">",
"      Modan B, Ron E, Lerner-Geva L, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998; 147:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/64\">",
"      Brinton LA, Melton LJ 3rd, Malkasian GD Jr, et al. Cancer risk after evaluation for infertility. Am J Epidemiol 1989; 129:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/65\">",
"      Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 1995; 4:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/66\">",
"      Stuebe AM, Willett WC, Xue F, Michels KB. Lactation and incidence of premenopausal breast cancer: a longitudinal study. Arch Intern Med 2009; 169:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/67\">",
"      Zheng T, Holford TR, Mayne ST, et al. Lactation and breast cancer risk: a case-control study in Connecticut. Br J Cancer 2001; 84:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/68\">",
"      Tryggvad&oacute;ttir L, Tulinius H, Eyfjord JE, Sigurvinsson T. Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study. Am J Epidemiol 2001; 154:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/69\">",
"      Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002; 360:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/70\">",
"      Jernstr&ouml;m H, Lubinski J, Lynch HT, et al. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2004; 96:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/71\">",
"      Nichols HB, Berrington de Gonz&aacute;lez A, Lacey JV Jr, et al. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 2011; 29:1564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/72\">",
"      Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001; 358:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/73\">",
"      Lynch BM, Neilson HK, Friedenreich CM. Physical activity and breast cancer prevention. Recent Results Cancer Res 2011; 186:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/74\">",
"      Maruti SS, Willett WC, Feskanich D, et al. A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst 2008; 100:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/75\">",
"      McTiernan A, Kooperberg C, White E, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA 2003; 290:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/76\">",
"      Patel AV, Callel EE, Bernstein L, et al. Recreational physical activity and risk of postmenopausal breast cancer in a large cohort of US women. Cancer Causes Control 2003; 14:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/77\">",
"      Bardia A, Hartmann LC, Vachon CM, et al. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med 2006; 166:2478.",
"     </a>",
"    </li>",
"    <li>",
"     Willett WC, Rockhill B, Hankinson SE, et al. Nongenetic factors in the causation of breast cancer. In: Diseases of the Breast, 3rd, Harris JR, Lippman ME, Morrow M, Osborne CK (Eds), Lippincott, Williams and Wilkins, Philadelphia 2004. p.253.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/79\">",
"      Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med 1997; 336:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/80\">",
"      Brinton LA, Bernstein L, Colditz GA. Summary of the workshop: Workshop on Physical Activity and Breast Cancer, November 13-14, 1997. Cancer 1998; 83:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/81\">",
"      Irwin ML, Varma K, Alvarez-Reeves M, et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomarkers Prev 2009; 18:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/82\">",
"      Fairey AS, Courneya KS, Field CJ, et al. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2003; 12:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/83\">",
"      Ligibel JA, Campbell N, Partridge A, et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 2008; 26:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/84\">",
"      Band PR, Le ND, Fang R, Deschamps M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 2002; 360:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/85\">",
"      Hamajima N, Hirose K, Tajima K, et al. Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002; 87:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/86\">",
"      Chaturvedi P. Does smoking increase the risk of breast cancer? Lancet Oncol 2003; 4:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/87\">",
"      Reynolds P, Hurley S, Goldberg DE, et al. Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 2004; 96:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/88\">",
"      Cui Y, Miller AB, Rohan TE. Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat 2006; 100:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/89\">",
"      Miller MD, Marty MA, Broadwin R, et al. The association between exposure to environmental tobacco smoke and breast cancer: a review by the California Environmental Protection Agency. Prev Med 2007; 44:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/90\">",
"      Johnson KC, Miller AB, Collishaw NE, et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control 2011; 20:e2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/91\">",
"      Al-Delaimy WK, Cho E, Chen WY, et al. A prospective study of smoking and risk of breast cancer in young adult women. Cancer Epidemiol Biomarkers Prev 2004; 13:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/92\">",
"      Ambrosone CB, Kropp S, Yang J, et al. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/93\">",
"      Luo J, Margolis KL, Wactawski-Wende J, et al. Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ 2011; 342:d1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/94\">",
"      Anderson LN, Cotterchio M, Mirea L, et al. Passive cigarette smoke exposure during various periods of life, genetic variants, and breast cancer risk among never smokers. Am J Epidemiol 2012; 175:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/95\">",
"      Brennan SF, Cantwell MM, Cardwell CR, et al. Dietary patterns and breast cancer risk: a systematic review and meta-analysis. Am J Clin Nutr 2010; 91:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/96\">",
"      Boyd NF, Stone J, Vogt KN, et al. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer 2003; 89:1672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/97\">",
"      Thi&eacute;baut AC, Kipnis V, Chang SC, et al. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 2007; 99:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/98\">",
"      Cho E, Chen WY, Hunter DJ, et al. Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med 2006; 166:2253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/99\">",
"      Taylor EF, Burley VJ, Greenwood DC, Cade JE. Meat consumption and risk of breast cancer in the UK Women's Cohort Study. Br J Cancer 2007; 96:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/100\">",
"      Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008; 98:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/101\">",
"      Ganmaa D, Willett WC, Li TY, et al. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 2008; 122:2071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/102\">",
"      Ishitani K, Lin J, Manson JE, et al. Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 2008; 168:2022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/103\">",
"      Whittemore AS. Breast cancer in Marin County. Breast Cancer Res 2003; 5:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/104\">",
"      Kulldorff M, Feuer EJ, Miller BA, Freedman LS. Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol 1997; 146:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/105\">",
"      Vieira V, Webster T, Weinberg J, et al. Spatial analysis of lung, colorectal, and breast cancer on Cape Cod: an application of generalized additive models to case-control data. Environ Health 2005; 4:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/106\">",
"      Sturgeon SR, Schairer C, Gail M, et al. Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 1995; 87:1846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/107\">",
"      Henderson TO, Amsterdam A, Bhatia S, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med 2010; 152:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/108\">",
"      Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004; 141:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/109\">",
"      Guibout C, Adjadj E, Rubino C, et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol 2005; 23:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/110\">",
"      Pukkala E, Kesminiene A, Poliakov S, et al. Breast cancer in Belarus and Ukraine after the Chernobyl accident. Int J Cancer 2006; 119:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/111\">",
"      Ostroumova E, Preston DL, Ron E, et al. Breast cancer incidence following low-dose rate environmental exposure: Techa River Cohort, 1956-2004. Br J Cancer 2008; 99:1940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/112\">",
"      John EM, Kelsey JL. Radiation and other environmental exposures and breast cancer. Epidemiol Rev 1993; 15:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/113\">",
"      Hoffman DA, Lonstein JE, Morin MM, et al. Breast cancer in women with scoliosis exposed to multiple diagnostic x rays. J Natl Cancer Inst 1989; 81:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/114\">",
"      Dutkowsky JP, Shearer D, Schepps B, et al. Radiation exposure to patients receiving routine scoliosis radiography measured at depth in an anthropomorphic phantom. J Pediatr Orthop 1990; 10:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/115\">",
"      Andrieu N, Easton DF, Chang-Claude J, et al. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol 2006; 24:3361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/116\">",
"      Pijpe A, Andrieu N, Easton DF, et al. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ 2012; 345:e5660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/117\">",
"      Narod SA, Lubinski J, Ghadirian P, et al. Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol 2006; 7:402.",
"     </a>",
"    </li>",
"    <li>",
"     Shiftwork. IARC Monographs Volume 98. file://monographs.iarc.fr/ENG/Monographs/vol98/mono98-8.pdf (Accessed on November 01, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/119\">",
"      Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007; 8:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/120\">",
"      Megdal SP, Kroenke CH, Laden F, et al. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 2005; 41:2023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/121\">",
"      Hansen J, Stevens RG. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer 2012; 48:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/122\">",
"      Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 2005; 97:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/123\">",
"      Schernhammer ES, Berrino F, Krogh V, et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2008; 100:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/124\">",
"      Shin MH, Holmes MD, Hankinson SE, et al. Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst 2002; 94:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/125\">",
"      Knekt P, J&auml;rvinen R, Sepp&auml;nen R, et al. Intake of dairy products and the risk of breast cancer. Br J Cancer 1996; 73:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/126\">",
"      Boyd NF, Martin LJ, Noffel M, et al. A meta-analysis of studies of dietary fat and breast cancer risk. Br J Cancer 1993; 68:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/127\">",
"      Lin J, Manson JE, Lee IM, et al. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 2007; 167:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/128\">",
"      Missmer SA, Smith-Warner SA, Spiegelman D, et al. Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol 2002; 31:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/129\">",
"      Chung M, Lee J, Terasawa T, et al. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155:827.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.vitalstudy.org/ (Accessed on August 03, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/131\">",
"      Lin J, Cook NR, Albert C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 2009; 101:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/132\">",
"      Nagel G, Linseisen J, van Gils CH, et al. Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Breast Cancer Res Treat 2010; 119:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/133\">",
"      Takkouche B, Regueira-M&eacute;ndez C, Etminan M. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 2008; 100:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/134\">",
"      Zhang X, Smith-Warner SA, Collins LC, et al. Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol 2012; 30:3468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/135\">",
"      Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/136\">",
"      Rennert G, Pinchev M, Rennert HS. Use of bisphosphonates and risk of postmenopausal breast cancer. J Clin Oncol 2010; 28:3577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/137\">",
"      Chlebowski RT, Chen Z, Cauley JA, et al. Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol 2010; 28:3582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/138\">",
"      Newcomb PA, Trentham-Dietz A, Hampton JM. Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk. Br J Cancer 2010; 102:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/139\">",
"      Monsees GM, Malone KE, Tang MT, et al. Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 2011; 103:1752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/140\">",
"      Beral V, Bull D, Doll R, et al. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries. Lancet 2004; 363:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/141\">",
"      Melbye M, Wohlfahrt J, Olsen JH, et al. Induced abortion and the risk of breast cancer. N Engl J Med 1997; 336:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/142\">",
"      Erlandsson G, Montgomery SM, Cnattingius S, Ekbom A. Abortions and breast cancer: record-based case-control study. Int J Cancer 2003; 103:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/143\">",
"      Paoletti X, Clavel-Chapelon F. Induced and spontaneous abortion and breast cancer risk: results from the E3N cohort study. Int J Cancer 2003; 106:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/144\">",
"      Reeves GK, Kan SW, Key T, et al. Breast cancer risk in relation to abortion: Results from the EPIC study. Int J Cancer 2006; 119:1741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/145\">",
"      Michels KB, Xue F, Colditz GA, Willett WC. Induced and spontaneous abortion and incidence of breast cancer among young women: a prospective cohort study. Arch Intern Med 2007; 167:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/146\">",
"      Calle EE, Frumkin H, Henley SJ, et al. Organochlorines and breast cancer risk. CA Cancer J Clin 2002; 52:301.",
"     </a>",
"    </li>",
"    <li>",
"     Willett WC, Rockhill B, Hankinson SE, et al. factors in the causation of breast cancer. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Osborne CK (Eds), Lippincott, Williams and Wilkins, Philadelphia 2004. p.255.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/148\">",
"      Lipworth L, Tarone RE, Friis S, et al. Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study. Int J Cancer 2009; 124:490.",
"     </a>",
"    </li>",
"    <li>",
"     National Research Council. Breast Cancer and the Environment: A Life Course Approach. Institute of Medicine Report, National Academies Press; Washington, DC 2011.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/17/28954/abstract/150\">",
"      Kushi LH, Doyle C, McCullough M, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2012; 62:30.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 792 Version 27.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-F17749F6BC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28954=[""].join("\n");
var outline_f28_17_28954=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2446697319\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33001831\">",
"      STANDARD RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Increasing age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2354324740\">",
"      Female gender",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      White race",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9303004\">",
"      Weight",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9303037\">",
"      - Postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9303044\">",
"      - Premenopausal women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9303051\">",
"      Tall stature",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Estrogen exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33002095\">",
"      - Benign breast disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2354325194\">",
"      - Dense breast tissue",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1067591809\">",
"      - Bone mineral density",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1067591882\">",
"      Other hormonal factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2354326433\">",
"      - Androgens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9305674\">",
"      - Insulin pathway and related hormones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H439557597\">",
"      - In utero exposure to diethylstilbestrol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2354326496\">",
"      - Exogenous hormones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1067591470\">",
"      Reproductive factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H455514459\">",
"      - Earlier menarche or later menopause",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1067591498\">",
"      - Nulliparity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H455514540\">",
"      Infertility",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1067591505\">",
"      - Increasing age at first pregnancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1067591512\">",
"      - Absence of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1067592185\">",
"      Personal history of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1067592212\">",
"      Family history of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1067592239\">",
"      Inherited genetic mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2446695404\">",
"      LIFESTYLE FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2446695412\">",
"      Physical inactivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H106517866\">",
"      Alcohol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2446695419\">",
"      Smoking",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2446696258\">",
"      DIETARY FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2446696265\">",
"      Dietary pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2446696272\">",
"      Fat intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2446696279\">",
"      Red meat and processed meat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9304760\">",
"      Soy/Phytoestrogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9304767\">",
"      Caffeine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2446696286\">",
"      ENVIRONMENTAL FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2446696293\">",
"      Geographic residence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2446696300\">",
"      Exposure to ionizing radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2446696314\">",
"      Night shift work",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9305001\">",
"      MEDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9305250\">",
"      Calcium/Vitamin D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9305257\">",
"      Antioxidants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9305267\">",
"      Nonsteroidal anti-inflammatory drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9305274\">",
"      Bisphosphonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9304529\">",
"      FACTORS THAT DO NOT INFLUENCE BREAST CANCER RISK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9304554\">",
"      Abortion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H106517721\">",
"      Chemicals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86339679\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9303838\">",
"      QUANTIFYING RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2446697232\">",
"      REDUCING BREAST CANCER RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2446697319\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/792\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/792|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/41/29342\" title=\"figure 1\">",
"      SEER incidence breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/792|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/33/22043\" title=\"table 1\">",
"      Risk devel BC white women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/52/16205\" title=\"table 2\">",
"      Risk factors breast cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/38/11884\" title=\"table 3\">",
"      Breast cancer genes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/5/17498?source=related_link\">",
"      Benefits and risks of caffeine and caffeinated beverages",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40842?source=related_link\">",
"      Bisphosphonates in the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/36/26186?source=related_link\">",
"      Breast cancer in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/24/42378?source=related_link\">",
"      Cancer prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=related_link\">",
"      Characteristics of hereditary breast and ovarian cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/49/10009?source=related_link\">",
"      Clinical features, diagnosis, and staging of newly diagnosed breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/55/11128?source=related_link\">",
"      Diagnosis and evaluation of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2601?source=related_link\">",
"      Dietary fat",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34441?source=related_link\">",
"      Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=related_link\">",
"      Health hazards associated with obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3322?source=related_link\">",
"      Outcome and follow-up of diethylstilbestrol (DES) exposed individuals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11081?source=related_link\">",
"      Overview of benign breast disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=related_link\">",
"      Overview of ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/61/38874?source=related_link\">",
"      Overview of the risks and benefits of alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/35/33336?source=related_link\">",
"      Overview of the use of osteoclast inhibitors in early breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/6/44134?source=related_link\">",
"      Patient information: Factors that modify breast cancer risk in women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13034?source=related_link\">",
"      Physiology and clinical use of melatonin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/11/11449?source=related_link\">",
"      Postmenopausal hormone therapy and the risk of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=related_link\">",
"      Postmenopausal hormone therapy: Benefits and risks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/51/2872?source=related_link\">",
"      Risk prediction models for breast cancer screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=related_link\">",
"      Risks and side effects associated with estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/49/41754?source=related_link\">",
"      Screening for breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/26/35242?source=related_link\">",
"      Second malignancies after treatment of classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44246?source=related_link\">",
"      Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_17_28955="Indications and contraindications laparoscopic cholecystectomy";
var content_f28_17_28955=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F76254&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F76254&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications and contraindications for laparoscopic cholecystectomy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Indications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Symptomatic cholelithiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Biliary colic, acute cholecystitis, gallstone pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Asymptomatic cholelithiasis in select cases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sickle cell, TPN, immunosuppression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acalculous cholecystitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gallbladder dyskinesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Large gallbladder polyps",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Porcelain gallbladder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Contraindications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Absolute",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Inability to tolerate general anesthesia, peritonitis with hemodynamic compromise, refractory coagulopathy, gallbladder cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Relative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Previous abdominal surgery, pregnancy, morbid obesity, cholangitis, severe comorbidities",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28955=[""].join("\n");
var outline_f28_17_28955=null;
var title_f28_17_28956="Diseases of LIP on biopsy";
var content_f28_17_28956=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70714&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70714&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Lymphocytic interstitial pneumonia disease associations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Idiopathic without serum protein abnormality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acquired immunodeficiency syndrome - children and adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allogeneic bone marrow transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Autoimmune syndromes with dysproteinemias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sj&ouml;gren's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Primary biliary cirrhosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Myasthenia gravis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pernicious anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Autoimmune hemolytic anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Systemic lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Chronic active hepatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hashimoto's thyroiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Graves' disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Juvenile idiopathic arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Multicentric Castleman's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Multiple sclerosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Immune complexes - pulmonary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Dysproteinemias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hypogammaglobulinemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Monoclonal gammopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Polyclonal gammopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Common variable immunodeficiency (CVID)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Miscellaneous",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Celiac sprue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tuberculosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Graft-versus-host disease after stem cell transplant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Legionella infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Surfactant protein C deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Familial forms",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Cosgrove GP. Lymphoplasmocytic Infiltration of the Lung. In: Interstitial Lung Disease, Schwarz MI, King TW Jr (Eds), BC Decker, Hamilton 2003, p.827.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28956=[""].join("\n");
var outline_f28_17_28956=null;
var title_f28_17_28957="Aspirin provocation in AIA";
var content_f28_17_28957=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F65038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F65038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspirin provocation test in aspirin exacerbated respiratory disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 437px; height: 247px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Provocation test in which either placebo (blue dashed line) or aspirin (red solid line) was given to a patient with aspirin exacerbated asthma. The administration of aspirin led to a marked and transient reduction in FEV1.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28957=[""].join("\n");
var outline_f28_17_28957=null;
var title_f28_17_28958="Chronic irritant contact dermatitis";
var content_f28_17_28958=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50299&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50299&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic irritant contact dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 272px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ill-defined dry, scaly patches with fissuring on the finger in a patient with chronic irritant contact dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kulthanan K. Siriraj Hospital, Mahidol University, Bangkok, Thailand.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28958=[""].join("\n");
var outline_f28_17_28958=null;
var title_f28_17_28959="Temporal trends in incidence rates of ulcerative colitis";
var content_f28_17_28959=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F85903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F85903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 557px\">",
"   <div class=\"ttl\">",
"    Temporal trends in incidence rates of ulcerative colitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 537px; height: 370px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Temporal trends in incidence rates (cases per 100,000 person-years) of ulcerative colitis in selected geographic regions (Olmsted County, Minnesota",
"    <sup>",
"     [1]",
"    </sup>",
"    ; Rochester, New York",
"    <sup>",
"     [2]",
"    </sup>",
"    ; Iceland",
"    <sup>",
"     [3,4]",
"    </sup>",
"    ; Florence, Italy",
"    <sup>",
"     [5]",
"    </sup>",
"    ; Malmo, Sweden",
"    <sup>",
"     [6]",
"    </sup>",
"    ; Heraklion, Crete, Greece",
"    <sup>",
"     [7]",
"    </sup>",
"    ; and Seoul, South Korea",
"    <sup>",
"     [8]",
"    </sup>",
"    ).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000; 46:336.",
"      </li>",
"      <li>",
"       Stowe SP, Redmond SR, Stormont JM, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology 1990; 98:104.",
"      </li>",
"      <li>",
"       Bjornsson S, Johannsson JH, Oddsson E. Inflammatory bowel disease in Iceland, 1980-89. A retrospective nationwide epidemiologic study. Scand J Gastroenterol 1998; 33:71.",
"      </li>",
"      <li>",
"       Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000; 12:31.",
"      </li>",
"      <li>",
"       Trallori G, Palli D, Saieva C, et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol 1996; 31:892.",
"      </li>",
"      <li>",
"       Stewenius J, Adnerhill I, Ekelund G, et al. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol 1995; 30:38.",
"      </li>",
"      <li>",
"       Manousos ON, Giannadaki E, Mouzas IA, et al. Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol 1996; 8:893.",
"      </li>",
"      <li>",
"       Yang SK, Hong WS, Min YI, et al. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol 2000; 15:1037.",
"      </li>",
"     </ol>",
"     <br/>",
"     Reproduced from: Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126:1504. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_17_28959=[""].join("\n");
var outline_f28_17_28959=null;
